Population diversity as quantified by inter-population variation in patterns of linkage disequilibrium by ONG TWEE HEE
POPULATION DIVERSITY AS QUANTIFIED BY INTER-






ONG TWEE HEE 
(Msc (Bioinformatics)), NTU 
(Msc (Computer Science)), NUS 





A THESIS SUBMITTED  
 
FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 
 
SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH 
 








I hereby declare that the thesis is my original work and its has been written by me in 
its entirety. 
I have duly acknowledged all the sources of information which have been used in the 
thesis.  
 







ONG TWEE HEE 
16TH AUGUST 2012 
 i 
Acknowledgements 
This thesis would not have been possible without the guidance, support and 
help of many individuals. First, I would like to express my gratitude to my thesis 
advisor A/P Teo Yik-Ying for his guidance, encouragement and mentorship which 
helped support and steer me on course to complete this thesis in a timely manner. A/P 
Mark Seielstad who was my first mentor in the fields of population and medical 
genetics.  
My friends and colleagues in NUS Statistical Genetics Group and Genome 
Institute of Singapore who helped made this journey an enriching and educational 
process, and made me realize there’s much more one can do as a group collective 
effort than individually.  
This thesis builds on a large database of genetic data, whose collection, 
annotation and validation would not have been possible without the time and hard 
work put together by many people involved in these studies, and the generosity of 
volunteers who were enrolled and consented to having their genetic information made 
available anonymously for scientific advancements in genetics.   
  
 ii 
Table of Contents 
Summary ..................................................................................................................v 
List of Tables ........................................................................................................ vii 
List of Figures ...................................................................................................... viii 
Publications ............................................................................................................ xi 
Chapter 1 – Introduction ..........................................................................................1 
Linkage Disequilibrium in the Human Genome .............................................1 
Natural Selection ....................................................................................1 
Population Structure...............................................................................3 
Measures of Linkage Disequilibrium..............................................................3 
Haplotype Phase..............................................................................................6 
Methods to visualize Linkage Disequilibrium ................................................6 
Haplotype Blocks ............................................................................................7 
Disease Gene Mapping by Linkage Disequilibrium .......................................8 
International HapMap Project (HapMap) .....................................................10 
Linkage Disequilibrium in Genome-Wide Association Studies ...................12 
Chapter 2 – varLD : a program for quantifying variation in linkage disequilibrium 
patterns between populations ........................................................................14 
Motivation .....................................................................................................14 
Methods.........................................................................................................15 
Quantification of LD ............................................................................15 
Eigen-analysis of regional LD between two populations ....................16 
Computation of Monte Carlo statistical significance ...........................16 
Genome-wide quantification of varLD scores .....................................17 
Software Implementation .....................................................................18 
Results ...........................................................................................................19 
Window size of SNPs ..........................................................................19 
Portability of Association Signals and Differential LD .......................20 
Factors of Differential LD Patterns ...............................................................21 
Haplotype Frequency ...........................................................................21 
Natural Selection ..................................................................................22 
 iii 
Structural Variants ...............................................................................22 
Example Application ....................................................................................24 
Discussion .....................................................................................................25 
Summary .......................................................................................................27 
Chapter 3 – Singapore Genome Variation Project: a haplotype map of three 




SNP Genotyping and Quality Assessment ...........................................29 
Population Structure.............................................................................31 
Haplotype Phasing and Diversity.........................................................31 
Analysis of LD .....................................................................................32 
Detecting signatures of recent positive selection .................................33 
Results ...........................................................................................................35 
Population Structure.............................................................................35 
LD differences and Haplotype Variation .............................................38 
Signatures of positive natural selection ...............................................41 
Discussion .....................................................................................................42 
Summary .......................................................................................................44 
Chapter 4 – Trans-ethnic genome-wide association studies meta-analysis for 
association discovery and fine-mapping of causal variants ..........................46 
Motivation .....................................................................................................46 
Methods.........................................................................................................48 
Simulated case-control datasets ...........................................................48 
Association and meta-analyses ............................................................49 
Population diversity metrics ................................................................50 
Regional FST ...............................................................................51 
Haplotype Entropy ......................................................................51 
Haplotype Similarity ...................................................................51 
Composite varLD ........................................................................52 
Application to T2D implicated loci .....................................................52 
Results ...........................................................................................................54 
 iv 
Genome-wide population diversity ......................................................54 
Regional population diversity ..............................................................59 
Application to Type 2 Diabetes implicated loci ..................................67 
Discussion .....................................................................................................68 
Summary .......................................................................................................70 
Chapter 5 – A method for identifying haplotypes carrying the causative allele in 
genome-wide association studies and positive natural selection ..................71 
Motivation .....................................................................................................71 
Methods.........................................................................................................72 
Algorithm for Type 1 ...........................................................................73 
Algorithm for Type 2 ...........................................................................74 
Algorithm for Type 3 ...........................................................................75 
Fuzzy Matching in Type 2 and Type 3 ................................................76 
Software implementation and output format .......................................76 
Dataset..................................................................................................77 
Results ...........................................................................................................78 
HapFinder Type 1 ................................................................................78 
HapFinder Type 2 ................................................................................80 
HapFinder Type 3 ................................................................................82 
Discussion .....................................................................................................85 
Summary .......................................................................................................86 





Linkage disequilibrium (LD) is the non-random association of alleles at 
adjacent loci, where combinations of alleles occur more frequently than expected for 
independently segregating alleles in a population. The presence of LD between single 
nucleotide polymorphisms (SNPs) has enabled the success of commercial genotyping 
platforms with incomplete coverage of the human genome to successfully identify 
genes implicated in complex human diseases and traits through genome-wide 
association studies (GWAS). However, population differences in extents of LD 
between the causal variant and the SNPs genotyped could result in failure of 
replicating the association signals across different populations. We thus developed a 
method, varLD that can be used to provide a quantitative measure of LD variations 
between populations by allowing both genome-wide assessment and targeted analysis 
of specific genomic regions. The first generation of commercial genotyping arrays 
used in GWAS studies were designed based on LD patterns observed from four 
human population groups in the HapMap Project Phases I and II, and it was then 
unclear how applicable these LD patterns are to other human populations. We 
therefore assembled a resource of genetic variation data on the three local population 
groups in Singapore: Chinese; Malays and Indians to assess the genetic diversity 
within Singapore and in comparison with the four HapMap populations: investigating 
if the genetic diversity of LD variation as quantified by varLD could have any 
implications for GWAS studies conducted on these local populations. LD, which was 
beneficial in the initial association discovery phase of GWAS becomes a liability in 
fine-mapping studies as it is difficult to differentiate between the causal variant and 
neighboring SNPs that are in strong or perfect LD with the causal variant, showing 
indistinguishable evidence of statistical association. By the nature of LD, most if not 
all of the associated alleles, including the causal variant should be found on the same 
 vi 
haplotype in a population. Our results on simulated data suggest that by leveraging on 
the differential LD patterns and haplotypes from diverse populations in the fine-
mapping of a common associated genomic region, we can localize and identify the 
causal variant within the region. Measures of LD and haplotype diversity such as 
varLD and haplotype similarity, can be used to identify regions or populations where 
trans-ethnic fine-mapping are likely to succeed in localizing the causal variant, while 
measures such as regional FST and haplotype entropy can be used to assess the 
reproducibility of association signals in trans-ethnic meta-analysis of association 
discovery. We also developed a method, HapFinder that can be used to identify the 
haplotype forms carrying most if not all of the risk alleles identified from GWAS 
studies for different populations which subsequently can be used to localize the causal 
variant to regions where these population-specific haplotypes are consistent across 
populations. In addition, we show that HapFinder can also be used to identify the 
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Chapter 1 – Introduction 
LINKAGE DISEQUILIBRIUM IN THE HUMAN GENOME 
Throughout the human genome, a non-random correlation exists between the 
alleles at neighboring loci, such that knowing the allele at one locus, the allele at an 
adjacent locus can be inferred with considerable confidence. This correlation structure 
between alleles is known as linkage disequilibrium (LD). LD arises when a series of 
mutations have occurred at adjacent loci and is gradually destroyed by recombination 
(Figure 1). The extent of LD is therefore expected to decrease as a function of time t 
and recombination frequency r between markers. The rate of decay of LD can thus be 
represented by the following formula1, where D0 is the extent of LD at an initial time 
t0 and Dt is the extent of LD at time t generations later: 
𝐷𝑡 =  (1 − 𝑟)𝑡𝐷𝑜 
 
Besides mutation and recombination, other population genetic forces also play 
important roles in determining the extent of LD levels in the human genome. These 
population genetic forces include those that act on LD throughout the human genome 
related to the characteristics of a population such as genetic drift, population 
admixture and population structure, and those that act on specific regions of the 
human genome such as gene conversion and natural selection. 
 
Natural Selection 
Majority of the genetic variation in humans are functionally neutral and do not 
have a consequence on fitness which is defined as the ability to both survive and 
reproduce. For an advantageous allele that has an impact on fitness, strong positive 
selection will rapidly increase the frequency of the haplotype carrying the selected 
allele to high frequency or even fixation in the population by a process known as 
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genetic hitch-hiking. This will result in the linked neutral loci to remain in strong LD 
with the selected allele and thus reducing the heterozygosity at these neutral loci in 
the population. Several methods2-4 have thus been developed to detect such regions of 
unusually low heterozygosity that could indicate past events of genetic hitch-hiking.  
 
 
Figure 1 How LD arises, and how it is disrupted by recombination using a 2 locus example.  
a) In the beginning, no mutation has occurred at both locus on the haplotype, and therefore the alleles 
at both loci are of the ancestral reference alleles (A, B). b) A mutation at the first locus has resulted in 
this locus to be polymorphic with the alleles A and a, and thus generating two haplotypes. c) A second 
mutation then occurred at the second locus changing the allele B to b. This can happen on either of the 
haplotypes having the alleles A or a. (A in this example). Now, only 3 of the 4 possible 2-loci 
haplotypes will be present in the population, with the A allele always found when the b allele is 
observed, and the B allele always present when the a allele is observed. However, this association 
between the alleles at the 2 loci will gradually be disrupted when recombination occurs between the 
loci. d) This will result in having all 4 possible 2-loci haplotypes in the population, and thus a reduction 
of the LD between the 2 loci in the population. 
 
If the advantageous allele has not achieved fixation in the population, the 
levels of variation at the linked loci would be much lower on chromosomes carrying 
the selected allele than on other chromosomes. Computational efficient methods for 
neutrality tests of haplotype variability at the selected locus5-7 have since been 
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developed to identify such positively selected regions and successfully applied on 
large population genetic datasets. 
 
Population Structure 
Changes in population sizes particularly in situations of extreme reduction 
such as a population bottleneck can amplify the effects of genetic drift, where some 
haplotypes could be lost from the population. This reduces genetic variation and 
consequently increases LD in the population. The higher levels of LD detected in the 
non-African populations such as the Europeans and East Asians as compared to the 
African population groups have thus been widely attributed as a result of the 
population bottleneck that occurred during the modern human expansion out of 
Africa8-10.  
Population admixture occurs when a new population group is created through 
the mixing of two or more previously distinct groups. This fusion of population 
groups is actually relatively common in human history due to our migratory patterns. 
One such admixture population group is the African Americans whose gene pool is 
made up of ethically diverse African populations and people of mainly European 
descent. Initially the differences in allele frequencies of these distinct populations will 
generate ‘spurious’ LD even between unlinked markers which should be rapidly 
removed in subsequent generations. However the breakdown of LD between nearby 
linked markers will proceed at a much slower rate by the regular process of 
recombination.    
 
MEASURES OF LINKAGE DISEQUILIBRIUM 
Independence between two alleles, or linkage equilibrium11 is defined such 
that given two bi-allelic loci with alleles denoted as A/a and B/b and the probability of 
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recombination between them is non-zero, then the frequency of each two-loci 
haplotype is equal to the product of the allele frequencies, i.e. PAB = PAPB. Linkage 
disequilibrium which implies a dependence or correlation between the two alleles, is 
therefore a measure of the deviation from this equilibrium expectation. 
D, which is the earliest measure of LD proposed, is a direct measure of the 
difference between the observed frequency of a two-locus haplotype and the expected 
frequency if the alleles are randomly independently segregating12, i.e DAB = PAB - 
PAPB. If both loci are bi-allelic as is in the case of SNPs then only one value of D is 
needed to represent the LD between the two loci since DAB = -Dab = -DaB = Dab. 
Therefore D can be used without a subscript to represent all alleles and the sign of D 
is arbitrary depending on which allele is used as the reference. Several LD measures 
have been proposed for multi-allelic loci13; 14 but none was widely accepted. The 
numerical value of D is however of little use in measuring the strength and comparing 
of the extent of LD due to its dependence on the frequencies of the alleles in the loci 
considered. For example, if PA  =  0.9 and PB  =  0.9, then the maximum value of D = 
0.09 when PAB  = 0.9, and if PA = 0.5 and PB = 0.5, then the maximum value of D = 
0.25 when PAB = 0.5. To resolve this dependency on the allele frequency, a 
standardized measure, Lewontin D’ was therefore proposed15.  
 




𝑃𝐴𝐵 −  𝑃𝐴𝑃𝐵min(𝑃𝐴𝑃𝑏 , 𝑃𝑎𝑃𝐵)      𝑖𝑓 𝑃𝐴𝐵 −  𝑃𝐴𝑃𝐵 > 0
𝑃𝐴𝐵 −  𝑃𝐴𝑃𝐵min(𝑃𝐴𝑃𝐵, 𝑃𝑎𝑃𝑏)      𝑖𝑓 𝑃𝐴𝐵 −  𝑃𝐴𝑃𝐵 < 0         
 
Now, D’ = 1 for both of the previous examples and this is known as the case 
of complete LD. D’ = 1 if and only if 3 of the 4 possible haplotypes are observed in 
the population, indicating that no recombination has occurred between the two 
markers. Values of D’ < 1 indicate that recombination has occurred between the two 
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markers, and therefore the complete ancestral LD has been disrupted. The relative 
magnitude of D’ < 1 also has no clear interpretation with regards to the strength and 
extent of LD level. For small sample sizes, or markers with rare alleles, the estimates 
of D’ are strongly inflated and thus high values of 𝐷’ are possible even when the 
markers are in linkage equilibrium.  
  𝑟2 =  𝐷2
𝑃𝐴𝑃𝑎𝑃𝐵𝑃𝑏
      
Another commonly used LD measure is r2 which is also known as the 
correlation coefficient between a pair of alleles at the two loci. r2 = 1 is known as the 
situation of perfect LD and occurs if and only if the two markers have not been 
disrupted by recombination and have the same allele frequency, where only exactly 
two of the four possible two-loci haplotypes are observed. This implies that the 
observations at one locus is able to provide complete information about the second 
locus, or alternatively the genotype at one locus is able to predict exactly the genotype 
at the second locus. Intermediate values of r2 are also easily interpretable, since it 
relates to the extent of correlation between the two markers taking into account the 
differences in allele frequencies. These properties thus make r2 the preferred choice of 
measurement for quantification and comparison of levels of LD for the purposes of 
phenotype and/or disease mapping16. Consider a two-loci example where the first 
locus is functionally associated with the phenotype of interest and the second locus is 
a marker that is in LD = r2 with the first susceptibility locus. In order to detect the 
phenotypic association at similar levels of power, we will need to increase the sample 
size required by approximately 1/r2  if we genotyped the second locus marker as 
compared to the sample size needed if we had genotyped the true causal susceptibility 




For the various LD measures, it is implicitly assumed that the haplotypes are 
known, but most often only the genotypes at the different loci of an individual can be 
determined. For an individual typed at three loci and having the genotypes of aa Bb 
Cc, there could be two possible combinations of haplotypes: aBC/abc or abC/aBc. 
Knowing the genotypes for both parents of this individual could but not always 
determine the correct haplotype forms especially if more loci are considered and are 
heterozygous. The process of determining haplotypes from genotype data is 
commonly known as resolving the haplotype phase and several statistical methods are 
available based on principles of maximum likelihood17, parsimony18, combinatorial19 
or coalescent20 theories. We note that there is uncertainty in the inference of the 
phasing procedure and this could be important for rare haplotypes but for common 
haplotypes, reasonable results can be achieved. It is therefore common to use one of 
these statistical phasing methods to infer the haplotypes from genotype data and apply 
it in the calculation of LD measures. Methods exist for direct calculation of LD from 
genotype data21 but this approach is not often used as without information of 
haplotype phase, the signals of nonrandom association are significantly weakened22. 
 
METHODS TO VISUALIZE LINKAGE DISEQUILIBRIUM 
When examining the extents of LD between more than two loci, for example 
in a genomic region with 100 SNP markers, it is generally easier to view the results 
graphically to differentiate between pairs of SNPs with high LD from those with low 
LD than it is to sort through 4,950 rows of values for all possible pairwise 
combinations. One visualization technique is the use of a LD heatmap14; 23, which is 
to represent the extents of LD measures with different colors or intensity shades 
corresponding to the values of LD measurements (Figure 2). The use of LD map24 is 
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another alternative where an exponential decay function is fitted to the D’ values and 
the decay parameter of the function providing a measure of the local LD in the region. 
 
HAPLOTYPE BLOCKS 
In the beginning of the 21st century, various studies25-27 have provided 
empirical evidence of the existence of block-like regions in humans where each non-
overlapping block contains loci that are in strong LD with each other and low or no 
LD exists between loci in different blocks (Figure 2). Each block is known as a 
haplotype block and the boundaries between blocks were shown to be highly 
recombinant. The existence of haplotype blocks in humans meant that it might be 
possible to just test one or few SNPs within each block in case-control experiments 
for disease association, thereby significantly reducing the number of markers that 
need to be assayed28. However, not all regions in the human genome were such block-
like29 and different ways of haplotype block definition resulted in different 
boundaries25; 27 and most importantly, these blocks varied across different human 




Figure 2 LD Heatmap and Haplotype Block  
Screenshots are taken from Haploview23 version 4.2 with the sample files provided for 20 markers in 
40 trios (120 individuals), with the LD color scheme and values set to be r2, while haplotype block 
analysis is based on confidence interval. Other color encoding schemes and haplotype block analysis 
methods exist in Haploview. LD values of r2 for each pair of markers are displayed in the 
corresponding cells, for example the LD between the first marker IGR1118a_1 and tenth marker 
IGR1373a_1 is 0.57, and the method to determine the corresponding box for the two markers are 
enclosed in red boxes. For an overview of the LD patterns for all markers in the region, the strength of 
all pairwise LD values are also illustrated using colors encoding where r2 = 0 is represented by white, 
and r2 = 1 is represented by black, and intermediate values of r2 are represented by shades of grey. The 
strong levels of LD among clusters of markers also result in the definition of haplotype blocks where 
within each haplotype block there is little or no evidence of recombination between the markers. The 
above example shows three blocks that are defined for this region of markers.  
 
DISEASE GENE MAPPING BY LINKAGE DISEQUILIBRIUM 
Complex diseases such as obesity, diabetes, inflammatory diseases and cancer 
are caused by combinations and interactions of genetic and environmental factors. It 
is therefore important to identify the genetic variants that will predispose an 
individual susceptible for the disease in order to understand the etiology and 
pathogenesis of the disease which will lead to prevention, early disease detection and 
better clinical treatment.  
 9 
One approach in identification of the genetic causal variant would be to test 
each putative genetic variant for association with the disease. This can be done by 
comparing two groups of individuals: one affected and the other unaffected with the 
phenotype of interest, such as in a case-control study. If the genetic variant is 
associated with the disease, then there should be a much higher excess of the 
susceptibility allele present in the cases as compared to the controls than expected by 
chance. However, to search and identify all genetic variants in a large sample of 
individuals is not feasible technically and economically.  
 
 
Figure 3 SNPs, Haplotypes and Tag SNPs.  
Figure is taken from REF31 a) We first identify the set of SNPs (their genomic positions and alleles) 
that are common in a large number of individuals. b) Common haplotypes with the various 
combinations of alleles in the SNPs are then identified. c) Tag SNPs which can uniquely identify these 
common haplotypes are identified, which are then used for association testing to reduce the number of 
variants to be tested. 
 
The widespread occurrence of SNPs and the existence of haplotype block 
structure in the human genome therefore provide a method of mapping the disease 
genes. By first identifying the haplotype blocks and the common haplotypes, we can 
determine the tag SNPs that are able to uniquely identify the common haplotypes, 
which can then be used for association testing. This will greatly reduce the number of 
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SNP markers that need to be tested for association, reducing time and costs (Figure 
3). These SNPs are usually not the causal variants directly responsible for the 
phenotype, but are markers that are in strong LD with the underlying causal variants. 
Thus, the association of genotyped SNPs with the phenotype of interest merely serve 
as indicators for genomic regions containing the causal variants that are directly 
affecting the outcome of the phenotype. This however relies on the existence of a 
genome-wide map of LD in the human genome for diverse populations. 
 
INTERNATIONAL HAPMAP PROJECT (HAPMAP) 
The International HapMap Project (HapMap) initiated in 2002 was an 
international collaborative effort to catalog the common genetic variation, primarily 
SNPs and determine the extents of LD and haplotype blocks in the human genome for 
individuals with ancestry from parts of Africa, Asia and Europe. It was hoped that 
most of the common haplotypes in all human populations would thus be identified in 
this project.  
In Phase 1, the goal is to identify at least one common SNP, defined as the 
minor allele occurring in at least 5% of the population at intervals of 5 kb in the 
genomes of individuals with ancestries from Africa, Asia and Europe31; 32. Samples 
with African ancestry comprised of 30 trio Yoruba families with both parents and a 
child from the Ibadan region of Nigeria (YRI). 90 unrelated individuals of Asian 
ancestries were assembled, with 45 Han Chinese residing in Beijing China (CHB), 
and the rest Japanese individuals residing in Tokyo Japan (JPT). 30 US trio families 
from the collection of Centre d’Etude du Polymorphisme Humain with northern and 
western European ancestries (CEU) were also included. 
In Phase 2, the same individuals were genotyped for an additional 2.1 million 
SNPs which resulted in a catalog of over 3.1 million SNPs with SNP density of 1 SNP 
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per 1kb and is estimated to capture 25-30% of all common SNPs in humans33. Besides 
having a denser SNP density, SNPs with lower minor allele frequency (MAF < 5%) 
were also genotyped in Phase 2 which resulted in a better resolution of the LD 
patterns, recombination events and better coverage of the common variation in the 
human genome. The haplotype map constructed in Phase 2 thus provides the most 
comprehensive resource for selection of tag SNPs genome-wide. Using a pairwise 
tagging approach with threshold r2 ≥ 0.8, it was initially estimated that about a million 
SNPs are necessary to capture all the common variation in YRI, while about half a 
million SNPs are required in CEU and JPT+CHB respectively.    
Phase 3 of HapMap attempts to examine both common and rare SNPs, 
together with copy number polymorphisms (CNPs) in a larger sample of individuals 
with a wider range of ancestries34. Individuals from seven additional human 
populations were included to the original four populations. These additional 
populations were (i) individuals with African ancestry in southwestern United States 
(ASW) (ii) Chinese in Metropolitan Denver Colorado United States (CHD) (iii) 
Gujarati Indians in Houston, Texas United States (GIH) (iv) Luhya in Webuye, Kenya 
(LWK) (v) Maasai in Kinyawa, Kenya (MKK) (vi) individuals with Mexican ancestry 
in Los Angeles, California, United States (MXL) and (vii) Tuscans in Italy (TSI).   
HapMap thus provided a valuable resource to facilitate the development of 
commercial SNP genotyping arrays in the selection of SNP content to be assayed in 
genome-wide association studies based on the pairwise LD tagging approach of 
SNPs. Various independent studies have shown that although the tag SNPs on these 
SNP arrays were chosen from only three population panels with 270 samples, these 
tag SNPs were able to capture most of the common variation in other diverse human 
populations35; 36. 
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LINKAGE DISEQUILIBRIUM IN GENOME-WIDE ASSOCIATION STUDIES 
Identification of any novel genetic variants in genome wide association studies 
(GWAS) is usually deemed as a putative finding, unless the association can be 
replicated in independent studies, usually of different population groups. In order to 
identify genetic variants of smaller effects, it is now common to pool samples from 
multiple distinct studies to increase the effective sample sizes to number tens of 
thousands or more individuals in meta-analysis studies. Failure to replicate a genuine 
finding may happen when the associated typed marker is in high LD with the causal 
variant in the initial discovery study population but not in the replication populations. 
It is therefore necessary that we are able to quantify the extents of LD variation across 
populations to determine if non-replication of association signals could be a result of 
differential LD patterns between populations, which is the objective of Study 1 in this 
thesis.  
The early GWAS studies were conducted primarily on populations of 
European ancestries and thus the tag SNP selection for the content on the first 
generation of commercial SNP arrays were biased towards the HapMap CEU 
population. The SNPs selected were usually polymorphic in CEU to maximize the 
genomic coverage in CEU, with lower genomic coverage for the Asians and Africans. 
Although several studies have demonstrated the transferability of tag SNPs selected 
from HapMap to other diverse human population groups, these are usually restricted 
to specific regions in the genome and are generally not a genome-wide comparison.  
Singapore is a young nation with majority of its current citizens the 
descendants of immigrants with Chinese, Malay and Indian genetic ancestries from 
the neighboring countries of China, Malaysia, Indonesia and India. Study 2 thus 
attempts to provide a similar genetic resource as HapMap, for the 3 local population 
groups in Singapore which can be used to assess the genetic diversity between these 
populations and compare against the HapMap populations. We also aim to investigate 
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if the genetic diversity of LD variations could have any implications for GWAS 
studies conducted on the local populations in Singapore with the commercial 
genotyping platforms designed with SNPs selected from HapMap.  
The associated SNPs found in GWAS studies are most often genetic markers 
to indicate the likely genomic regions harboring the causal variant responsible for the 
phenotype of study. The next phase of medical genetic studies would be the fine-
mapping of such associated regions identified from GWAS studies to identify these 
causal variants. LD, which was beneficial in the initial association discovery phase of 
GWAS studies now becomes a liability in fine-mapping of causal variant as it 
becomes difficult to differentiate between the causal variant and the neighboring 
SNPs that are in strong or perfect LD with the causal variant, as these yield 
indistinguishable evidence of statistical association between the causal variants and 
surrogate markers to the phenotype/disease of study. By the nature of LD, most if not 
all of the alleles of these associated SNPs, including the causal variant should be 
found on the same haplotype in the population. It has been shown that by leveraging 
on the differential patterns of LD and haplotypes from diverse populations in fine-
mapping of the associated loci, we can localize and identify the causal variant within 
the associated region. Study 3 thus aims to investigate if there are any metrics of 
population diversity that will be useful for the purposes of: (i) identify regions or 
populations where trans-ethnic fine-mapping of causal variants are likely to succeed;  
and (ii) also to identify regions or populations where a trans-ethnic meta-analysis of 
loci for association discovery identification will likely yield the best consistent results 
for association. In Study 4, we aim to develop a method which is able to identify the 
different haplotype forms carrying the associated risk alleles from multiple GWAS 
studies which can subsequently be used to localize the causal variant to regions where 
the identified associated haplotypes are consistent across the different populations in 
the multiple GWAS studies. 
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Chapter 2 – varLD : a program for quantifying variation in linkage 
disequilibrium patterns between populations 
MOTIVATION 
In genome-wide association studies (GWAS) of complex diseases and traits, 
the aim is to find statistically significant genetic markers associated with the 
phenotype of interest. These markers are usually non-functional and serve to indicate 
the likely genomic regions containing the unknown functional causal variants directly 
responsible for the phenotype. GWAS studies are commonly performed using 
commercial SNP genotyping arrays whose content were selected to maximize 
coverage of the human genome using various strategies such as linkage 
disequilibrium-based tagging panels37 or random collections38 across the human 
genome.  
To minimize the likelihood of false positives, the putative findings from the 
initial GWAS studies need to be replicated in other independent studies, usually on 
populations distinct from the initial study. In addition, to increase the statistical power 
for detecting genetic variants of smaller effects, it is now common to meta-analyze 
multiple GWAS studies of the same phenotype in tens of thousands or more 
individuals from diverse populations39-41. However, if there exists a genuine common 
causal variant in the associated locus across populations, differential levels of LD 
between the assayed markers and the unknown functional causal variant can confound 
replication of the association signals in some populations. This could occur if the 
associated assayed markers are in high LD with the causal variant in the initial study 
population but not in the replication populations. Therefore, in order to determine if 
non-replication of association signals could be a result due to differential LD patterns 
between populations, it is important that we are able to quantify the extent of inter-
population LD variation within the associated genomic regions. 
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METHODS 
Quantification of LD 
 
Figure 4 Opposing LD between populations.  
Figure is adapted from REF42. Consider an example of 2 SNP markers with alleles A/a and B/b, and the 
distribution of the two-marker haplotypes in two populations as shown. In population 1, allele A is 
correlated with allele B, while in population 2, allele A is correlated with allele b. Perfect LD (r2 = 1) 
exist in both populations, but D’ will be positive in one population and negative in the other population 
using the same reference allele. 
 
In GWAS studies, r2 is the most commonly used measure for assessment of 
LD between SNP markers. However,  r2 does not take into consideration the direction 
of LD between the alleles of the SNPs. Opposing LD is the situation where the 
correlation between two SNPs occur in opposite direction between the two 
populations, which is identifiable through D’ but not r2 (Figure 4). In GWAS studies, 
opposing LD will result in “flip-flop” associations where alternate alleles in the same 
SNP will be associated with the phenotype of study in different populations. We thus 
consider the use of signed r2 to quantify the extent of LD, which is the r2 metric with 
the sign of the D’ metric. A formal definition of signed r2 is as follows: for two bi-
allelic SNPs with alleles A/a and B/b in each locus respectively, and PAB as the 
frequency of the haplotype with alleles AB, PA; and Pa; PB; Pb denoting the 
respective allele frequencies, and I(PAB<PAPB) an indicator function which takes a 
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value of 1 if PAB<PAPB is true and 0 otherwise, then the formula for signed r2 is as 
follows- 




Eigen-analysis of regional LD between two populations 
We first consider the set of common S SNPs in populations 1 and 2, and 
divide them into (S – L + 1) overlapping windows of L SNPs, where each consecutive 
window is obtained by shifting the existing window one SNP forward. For a 
particular window of L SNPs, let M1 and M2 denote the two L X L symmetrical 
matrices in the two population respectively, where the (i, j) entry represents the signed 
r2 value obtained between SNP i and SNP j. Thus, each of these matrices M1 and M2 
is a correlation matrix between the L SNPs in each population using the LD measure 
of signed r2. It has been shown that testing for equality between the elements of two 
correlation matrices can be done by comparing the differences between the ranked 
eigenvalues of these two matrices43; 44.  We therefore perform an eigen-decomposition 
on each LD matrix, and obtain the sorted eigenvalues in descending order: ∆1 and ∆2 
for M1 and M2 respectively. We define the raw varLD score as the trace of |∆1 - ∆2 |, 
whose magnitude provides a measure for the extent of dis-similarity between the 
correlation matrices M1 and M2 that can also be used to quantify the extent of 
differences in LD between the two populations for the particular genomic region 
bounded by the window of L SNPs. 
   
Computation of Monte Carlo statistical significance 
To test the null hypothesis of no difference in extent of LD variation between 
the two populations of sizes n1 and n2 for a genomic region window of L SNPs, we 
can use a permutation procedure to obtain a Monte Carlo statistical significance. This 
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can be done where we first calculate the raw varLD score and define this as the 
empirical test statistic Temp. Assuming the null hypothesis of no difference in LD 
structure between the two populations, we can combine the genotype data from both 
populations into a single combined population of size n1 + n2. We then attempt to 
artificially recreate the two initial populations of sizes n1 and n2 by sampling the 
required number of samples from the combined population for both populations and 
calculate the corresponding varLD score, which is effectively a random selection 
from the null distribution. We define the Monte Carlo significance as (M+1)/(Niter+1), 
where M is the number of varLD score obtained from the re-sampling process that is 
larger than the empirical test statistic Temp and Niter the total number of permutations 
performed, of which a minimum of 10,000 is recommended. 
 
Genome-wide quantification of varLD scores 
For assessment of genome-wide data, it would be very computationally 
challenging to calculate a Monte Carlo significance for each window. Therefore, the 
relative rank of the varLD score of the window could be used as a estimate of the LD 
differences in that region as compared to the rest of the genome. A window would be 
considered as a candidate region containing substantial LD differences between the 
two populations if its associated varLD score is greater or equal to the 95th percentile 
distribution of all genome-wide varLD scores. The magnitude of the raw varLD 
scores are affected by the populations compared and number of SNPs in the window 
considered, therefore we choose to standardize the varLD scores to a mean of zero 
and standard deviation of one by the formula: si’ = (si – E(s)) / √var(s) , where E(s) 
and var(s) is the empirical mean and variance of the distribution of genome-wide 
varLD scores. We note that the standardized scores are not an approximation of the 
standard normal distribution, and we do not attach a statistical significance to the 
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varLD score by estimating an empirical p-value as the varLD scores are not obtained 
from a null distribution of no difference. 
Software Implementation 
The program varLD is implemented in the Java Programming language and 
runs on any operating system that supports v1.5 or above of the Java Runtime 
Environment (JRE).  varLD requires several external libraries such as (i) Apache 
Commons CLI library – for command line argument parsing; (ii) Apache Commons 
Primitives library; (iii) JAMA, a Java matrix package. These external libraries are all 
open source and freely available for download at their respective websites. Running 
varLD as a batch run for 22 autosomal chromosomes on about one million SNPs 
using the default parameters took approximately one hour on a machine with 2.0 GHz 
CPU and 16 GB RAM. 
The genotype input files per population should be tab-delimited with the 
following columns: rsid/snp-id,  chromosomal position,  first genotype, second 
genotype, etc; and the SNPs are assumed to be in ascending chromosomal order. 
Genotypes are to be encoded in numerals of 1,2,3,4 with the homozygote AA as 1, 
heterozygote Aa or aA as 2, homozygous aa as 3, and 4 as the missing genotype. The 
program varLD currently has the following features: 
 
i. SNP exclusion based on user-specified threshold on minor allele 
frequency, default = 0.05 
ii. SNP exclusion based on user-specified threshold for % of missing 
genotypes, default = 0.2 
iii. User-specified number of SNPs to consider in each window for 
genome-wide assessment 
iv. The same input file format is used for both genome-wide and targeted 
region assessment 
v. In targeted region assessment, users are able to specify the number of 
iterations to perform and a Monte-Carlo P-value will be generated. 
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RESULTS 
Window size of SNPs 
  
Figure 5 Comparison of identified regions with differential LD across varying window 
sizes.  
Figure is from REF42. This shows the comparison of the regions identified to be highly differentiated in 
levels of LD using varLD with standardized scores between HapMap CEU and WTCCC 58C across 
different number of SNPs in each window. Each point in the figure represents a region identified in the 
analysis with window size L=50, with its standardized score obtained versus that of  (A) window size 
L=25; (B) window size L=100; (C) window size L=200. The size and shade of each point indicates the 
relative size of the region with larger regions being indicated by larger circles with darker shades of 
gray. Circles with black shading indicate regions with sizes > 500kb. 
 
We first determine if the window size of SNPs might affect the regions 
identified to have differential LD patterns by performing four genome-wide 
comparisons between unrelated individuals in HapMap CEU and 60 randomly chosen 
individuals from the WTCCC 1958 British Birth Control Cohort dataset45 with 
varying window sizes of L = 25, 50, 100, 200 (Figure 5). We observed that with 
increasing SNP window sizes, there is reduced sensitivity in detecting differential LD 
regions of smaller sizes, particularly those in the top 5 percentile of the standardized 
varLD scores. However, as the same regions were identified to be most differentiated 
in LD variations regardless of the window size used, we chose L = 50 as the default 
window size of SNPs as a tradeoff between sensitivity of detection and SNP density, 
particularly given the density of commonly-used commercial SNP genotyping arrays.  
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Portability of Association Signals and Differential LD 
 To determine the portability of association signals across diverse populations, 
we first randomly select 300 genomic regions that were identified to be very 
differentiated in LD patterns between HapMap CEU and HapMap JPT+CHB, i.e. the 
top 5 percentile of the standardized varLD scores between these two populations. An 
additional 300 regions of similar sizes were also randomly selected without 
consideration of the LD patterns between the population pair across the human 
genome. For each region, we artificially simulate an effect size corresponding to a 
multiplicative risk of 1.3 for the minor allele in HapMap CEU and assume a baseline 
penetrance of 20% for the major allele homozygous genotype at a focal SNP that is 
assayed in both populations. To maintain the empirical LD structure in each 
population, we simulated a case control study of 2000 cases and 2000 controls in each 
population, where the two haplotypes for each individual are randomly selected from 
the phased haplotypes in the designated HapMap population, and the phenotype status 
as a binomial draw with probability given by the penetrance associated with the 
genotype at the focal SNP. We then ‘masked’ the focal SNP, and identify the SNP in 
HapMap CEU with the strongest association signal, and compare the level of 
significances in both HapMap CEU and HapMap JPT+CHB. It was observed that 
there was greater variability in the statistical levels of significances shown across the 
two populations in regions of strong differential LD, as compared to random selected 





Figure 6 Differences in statistical level of significances at the simulated focal SNP in 
HapMap CEU and JPT+CHB.  
Figure is from REF42. This shows the comparison of the –log10P-values obtained from association tests 
performed in case control study of 2000 cases and 2000 controls in each of the HapMap CEU and 
JPT+CHB populations for 300 pairs of genomic regions. Green and red circles represent differential 
statistical evidence in HapMap CEU and JPT+CHB respectively. (A) 300 genomic regions identified to 
be in top 5 percentile of varLD scores between HapMap CEU and HapMap JPT+CHB (B) 300 
randomly selected regions across the genome, where each region corresponds to one of similar size in 
regions described in (A).  
FACTORS OF DIFFERENTIAL LD PATTERNS 
Haplotype Frequency 
The presence of different dominant haplotypes in the populations could result 
in LD variation between these populations. Using the same 300 pairs of genomic 
regions identified earlier to be highly differentiated (top 5 percentile of standardized 
varLD scores) between HapMap CEU and HapMap JPT+CHB, we compared the 
differences in frequencies of the dominant haplotype in these regions between both 
populations. For each region, the dominant haplotype in CEU is first identified and 
the absolute difference in frequencies of this haplotype form between CEU and 
JPT+CHB is then calculated. We observed a significant correlation between the 
standardized varLD scores and the absolute difference in dominant haplotype 
frequencies (Pearson correlation coefficient = 0.25; P-value = 5.1 x 10-10), where each 
 22 
unit increase in varLD score correspond to an expected increase of 0.018 (95% CI: 
0.013 – 0.024) in the difference of dominant haplotype frequencies. This implies that 
regions with high standardized varLD scores, i.e. regions with strong differential LD 
patterns, also contain substantial haplotype differences between the populations. 
 
Natural Selection 
Regions in the genome that are strongly positive selected in a population 
would likely result in having differential haplotype composition from other 
populations which are not selected thus resulting in differential levels of LD between 
the populations. The LCT gene has been widely suspected to have been positively 
selected in the European populations46, by developing lactose persistence till 
adulthood due to reliance on diary products as a major staple food product in their 
diet. Performing the targeted varLD analysis with permutation to obtain a Monte-
Carlo statistical significance, the LD structure of the genomic region of the LCT gene 
is found to be significantly different between the Europeans of HapMap CEU and the 
East-Asians of HapMap JPT+CHB (P < 0.0001) and also with the Africans of 
HapMap YRI (P < 0.0001) but was not significant between East-Asians and Africans 
(P = 0.145). These results suggest that the contribution to differences in LD patterns 
primarily stem from structural genomic differences present in Europeans, which 
conforms with the established findings of positive selection at the LCT gene present 
only in CEU and not in YRI or JPT+CHB. 
 
Structural Variants 
Comparing across HapMap CEU and JPT+CHB, we observed that a 
significant proportion of the top 20 candidate regions  (8 out of 20) identified by 
varLD to be highly differentiated in LD structure also correspond to regions harboring 
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structural variants such as insertions, deletions and/or copy number variations in at 
least one of the populations compared (Table 1). This is also similar to the trend 
observed between other pairs of HapMap populations, where of the top 20 candidate 
regions identified by varLD, 7 and 11 of these regions were also identified to contain 
insertions and/or deletions between the populations of HapMap CEU and YRI and 
between HapMap JPT+CHB and YRI respectively42. We believe the presence of the 
structural variants of insertions and deletions could potentially confound the extent of 
LD in the region which will be over-represented by a list of homozygous genotypes 
due to the structural variant and therefore appear to be low in level of LD for the 
population thus resulting in significant differences in LD levels with another 
population that does not have the structural variant present in that region. 
 
Chr: start-end 
(Mb, hg17) Genes in region CNV region 
Chr1: 102.80 – 103.30 COL11A1 No 
Chr1: 106.53 – 106.99 N/A Yes47-50 
Chr1: 201.44 – 201.56 NFASC No 
Chr2: 52.30 – 52.62 N/A No 
Chr2: 149.82 – 150.50 C2orf25 No 
Chr3: 99.99 – 100.23 ST3GAL6, DCBLD2 No 
Chr3: 109.63 – 109.98 KIAA1524, DZIP3, RETNLB No 
Chr4: 26.99 – 27.42 N/A No 
Chr4: 73.17 – 73.47 GPR74 No 
Chr5: 103.29 – 103.60 N/A Yes47-51 
Chr7: 86.23 – 86.39 KIAA1324L No 
Chr9: 10.83 – 11.42 N/A Yes47-50 
Chr10: 111.42 – 111.48 N/A No 
Chr11: 82.93 – 83.66 DLG2 Yes47-50; 52 
Chr11: 100.11 – 100.60 PGR No 
Chr11: 131.36 – 131.44 HNT Yes53 
Chr13: 87.91 – 88.36 N/A Yes47-50; 54 
Chr13: 106.22 – 106.56 N/A Yes53 
Chr15: 46.04 – 46.67 SCL24A5, DUT, MYEF2, SLC12A1, FBN1 Yes47-51; 54 
Chr21: 24.31 – 24.34 N/A No 
Table 1: Top 20 candidate regions of significant LD differences between HapMap CEU and 
JPT+CHB. Table is from REF42. 
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EXAMPLE APPLICATION 
Warfarin is a widely used anticoagulant drug to reduce the tendency of blood 
clotting in patients suffering from stroke, thrombosis and heart attack. Warfarin 
activities however are determined partially by genetic factors where it has been shown 
that population specific haplotypes in the VKORC1 gene correlates with differences in 
warfarin dosage and response55; with the observation that Asian Indians required a 
higher dosage as compared to Chinese and Malays56. Based on the genome-wide 
assessment of standardized varLD scores, the VKORC1 gene region is shown  to 
display significant levels of LD variations between pairs of populations in HapMap   
and Singapore Genome Variation Project (SGVP) (Figure 7b).  
 
 
Figure 7 Signals of positive natural selection, LD structure and canonical haplotypes at 
VKORC1 gene.  
(a) |iHS| signals > 2 at 2Mbp region encompassing the VKORC1 gene for the populations in SGVP and 
HapMap (b) Distribution of standardized varLD scores for various pairwise populations in SGVP and 
HapMap (c) Haplotype assignment based on the canonical haplotypes identified in the region. 
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This region also consist of primarily three canonical haplotypes where the 
same dominant haplotype that confers resistance to warfarin is present in Europeans 
(HapMap CEU), Africans (HapMap YRI) and Asian Indians (SGVP INS), while the 
other two haplotypes that confer lesser susceptibility to warfarin suppression are 
dominant in Malays of SGVP MAS and the Far East Asian groups of HapMap CHB, 
HapMap JPT and SGVP CHS (Figure 7c).  
 
DISCUSSION 
Several reasons exist when a genetic variant shown to be associated to the 
phenotype of study in one population failed to replicate in a different population. If 
we believe the initial finding was true and indeed the same causal variant exists across 
the populations, then it is most probable that failure to replicate are likely due to: (i) 
the implicated risk allele of the associated SNP has different frequencies across the 
populations; (ii) differences in environmental effects across the populations resulting 
in a complex gene-environment interaction; and (iii) differing patterns in levels of LD 
between the causal variant and the assayed SNPs across the populations. The 
differential levels of LD across populations can potentially confound even large 
candidate gene studies by virtue of low statistical power due to the weak levels of LD 
between the assayed SNP and the causal variant57. It is therefore important to be able 
to assess the extent of LD differences between populations especially when there is a 
failure to replicate the initial findings in different populations. In our approach, the 
functional polymorphism or causal variant need not be assayed as varLD only utilizes 
the regional patterns of LD to identify variations across populations. There is however 
an implicit assumption that the extent of LD with nearby markers is sufficient long 
relative to the density of the assayed SNPs. With more GWAS studies performed on 
distinct populations to elucidate the genetic basis of complex human diseases, we 
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believe the assessment of LD variations between populations will become more 
common especially when evidence of associations differed between the populations.   
In performing genome-wide comparisons of LD between populations, our 
method prioritizes the regions located at the tails of the distribution of varLD scores 
(i.e. top 5%) to be significant, similar to the approach taken by several methods in 
detecting signatures of natural selection6; 7; 46. It is important to note that such a 
strategy only identifies regions that are more differentiated in LD patterns relative to 
the rest of the genome between the populations and does not attach any biological 
significance to these regions.    
The presence of structural variants such as insertions and deletions could 
result in erroneous genotype calling of SNPs in these regions, resulting in higher rates 
of missing data or misclassification of genotypes to be homozygous which are likely 
to bias and result in lower than expected levels of LD in these regions. It is therefore 
not surprising that most of the highly differentiated LD regions also contain 
population-specific copy number variants. We also note that genotyping errors in a 
large genomic region could have similar effects as structural variants in generating 
artificial signals of LD differences. We therefore advise checking candidate regions 
with strong LD differences for the presence of structural variants and genotyping 
errors to eliminate a false result. 
The long stretches of high levels of LD which was beneficial in GWAS 
studies for the initial identification of the associated genomic region would likely 
confound the fine-mapping for identification of the causal disease variant in the 
associated locus. If high levels of LD exist in the associated locus of the study 
population, fine-mapping by targeted re-sequencing will identify multiple neighboring 
genetic markers that are likely to be in near or perfect LD with the causal variant, 
resulting in a plateau of signals with similar statistical evidence of association, 
making the causal variant indistinguishable from these linked markers. It is currently 
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believed that by integrating data across different populations, one can leverage the 
diverse haplotypes and significant variations in LD patterns in these distinct 
populations to refine and localize the boundaries which the causal variant is likely to 
reside. This topic will be further explored with a novel methodological development 
in Chapter 5. 
 
SUMMARY 
We have introduced a novel method for quantitative assessment of the extent 
of LD structure between a pair of population and observed (i) a significant correlation 
between diverse LD variation and differences in haplotype distribution; (ii) regions of 
diverse differential LD variation could likely contain population specific structural 
variants like copy number polymorphisms that would confound assessment of levels 
of LD structure; (iii) if the replication and initial populations have diverse variation in 
LD structure in the associated region, even if a ‘true’ causal variant is present in both 
populations, portability of the association signals across the populations would be 
significantly affected. We have also showed that if genome-wide data on the 
populations are not available, a permutation strategy of the varLD method could still 










Chapter 3 – Singapore Genome Variation Project: a haplotype map 
of three Southeast Asian populations 
MOTIVATION 
By providing a dense resource of common genetic variation in the human 
genome across four population groups representing the broad genetic ancestries of 
Africans, Europeans and East-Asians, the International HapMap Project (HapMap)31-
33 has enabled the efficient selection of tag SNPs for the content on commercial SNP 
genotyping arrays which were instrumental to the success of the first generation of 
genome-wide association studies (GWAS). Previous studies had shown the 
transferability of these tag SNPs, although selected from only 210 unrelated samples 
in HapMap in three population panels, were able to capture most of the common 
genetic variation in other diverse human populations35; 36; 58. These studies however 
were generally restricted to specific genomic regions due to lack of genome-wide data 
from non-HapMap populations.   
Singapore, a Southeast Asian country located at the southern tip of the Malay 
Peninsula, is a young and diverse country with multiple cultures. Majority of the 
current local population are descendants of early migrants with Chinese, Malay and 
Indian genetic ancestries from the neighboring countries of China, Malaysia, 
Indonesia and India. In 2010, there are 3.7 million residents in Singapore, of which 
3.2 million are citizens with the ethnic composition of 74.1% Chinese, 13.4% Malay 
and 9.2% Indian59. The Chinese community are largely descendants of Han Chinese 
immigrants from the provinces of Fujian and Guangzhou in South China60, while the 
Indian community are largely descendants of ethnic Telugas and Tamils from 
southeastern India, and a minority of Sikhs and Pathans from north India60. Malays 
are broadly defined to consist of  descendants of indigenous Malays living in 
Singapore before the British colonization, and migrants of other Malay groups from 
Malaysia and Indonesia60.   
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The Singapore Genome Variation Project (SGVP)61 was thus initiated to 
create a genetic resource of genome-wide variation in the three local ethnic 
populations of Chinese (CHS), Malay (MAS) and Indians (INS). This chapter will 
focus on the comparison of the extent of genomic differences across these populations 
including comparisons of LD variation between populations in SGVP and HapMap 





We recruited 300 individuals (100 individuals each from Chinese, Malay and 
Indian ethnicity) for the SGVP study. These individuals were originally part of a 
larger inter-population study on genetic variability to drug response and were 
anonymously selected randomly to be part of the SGVP study, with only their 
ethnicity and gender known. Each individual in the SGVP study was also required to 
have their self-reported ethnicity identical to both sets of grandparents. Ethical 
consent for the original study on drug response and SGVP study were obtained from 
two independent Institutional Review Boards at the National University Hospital, 
Singapore and the National University of Singapore respectively. 
 
SNP Genotyping and Quality Assessment 
Genomic DNA for 292 individuals (99 Chinese, 98 Malay and 95 Indian) were 
assayed on both Affymetrix SNP6.0 Genotyping Chip and Illumina 1M-single DNA 
Analysis BeadChip following the respective manufacturers’ instructions. Three 
individuals, one from each ethnic group were genotyped twice for quality check. For 
Affymetrix SNP6.0 array, an initial sample QC was performed with the 3,022 control 
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probes on the array with genotype calls made using the DM algorithm62. Seven 
samples had call rates below 86% and were repeated; of which one sample was 
excluded when the repeated genotype call rate still failed to meet the 86% call rate 
threshold. The final set of genotype data from Affymetrix SNP6.0 array was then 
determined using the Birdseed algorithm63 as implemented in the Affymetrix Power 
Tools version apt-1.8.6 with version 2.6 of the model files and version na24 of the 
product files. Genotypes on the Illumina 1M array were called using its proprietary 
algorithm GenCall in the BeadStudio Program Suite64 with the default cluster-file 
from Illumina. A valid genotype call will be made only if the GC score is at least 
0.15, else the genotype will be considered as NoCall or missing.  
Quality assessment of the genotypes made were performed independently on 
each array platform, and consist of the following sequence of steps: (i) Preliminary 
SNP QC on all genotyped samples; (ii) Sample QC to remove problematic samples 
such as those with high rates of missingness; samples that could either be duplicates 
or genetically-related samples and samples whose reported ethnicity is not concordant 
with the genetically inferred population membership; (iii) a final iteration of SNP QC 
on all genotyped SNPs with the remaining samples. For common SNPs assayed on 
both Affymetrix and Illumina platforms, SNPs with concordance rates below 95% 
were removed from further analysis for both platforms. For the remaining common 
SNPs, we retain the genotypes from the platform with higher call rate, or from the 
Illumina platform when missing rates for both platforms are identical.  
This thus resulted in a dataset with 268 samples consisting of 1,584,040 SNPs 
for 96 Singapore Chinese (CHS); 1,580,905 SNPs for 89 Singapore Malays (MAS) 




Population structure of the samples in SGVP and HapMap were assessed with 
principal component analysis and FST. The pca program distributed in the software 
EIGENSTRAT65 was used to determine the first 20 principal components for various 
combinations of populations in SGVP and Hapmap on a thinned set of common SNPs 
to identify potential population outliers. Population structure differences were also 
accessed using both the weighted sample population FST defined in HapMap32 and the 
SNP-specific FST between pairs of populations in HapMap and SGVP. 
 
𝐻𝑎𝑝𝑀𝑎𝑝 𝑊𝑒𝑖𝑔ℎ𝑡𝑒𝑑 𝐹𝑆𝑇 = 1 −  ∑ �𝑛𝑗2 �∑ 2 𝑛𝑖𝑗𝑛𝑖𝑗−1 𝑥𝑖𝑗(1 − 𝑥𝑖𝑗)𝑖 / ∑ �𝑛𝑗2 �𝑗𝑗
∑ 2 𝑛𝑖
𝑛𝑖−1
𝑥𝑖(1 − 𝑥𝑖)𝑖  
where: 
xij = estimated frequency of the minor allele at SNP i in population j 
nij = number of chromosomes at SNP i 
nj = number of chromosomes analyzed in population j 
 
 
𝑆𝑁𝑃 − 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝐹𝑆𝑇 =  (𝑝1 − 𝑝2)2(𝑝1 +  𝑝2)(2 −  𝑝1 −  𝑝2) 
where: 
p1 and p2 denote the frequencies of a specific allele for the common SNP in both populations. 
 
Haplotype Phasing and Diversity 
The genotype data was phased independently for each population group and 
chromosome using the program fastPHASE66 with the number of haplotype cluster K 
set to 14 after empirical tests were performed to determine the optimal value based on 
the error rates obtained. We assessed the parameter K from 6 to 20, using the default 
of 20 expectation-maximization runs in fastPHASE, with each chromosome phased 
independently with ten iterations and in each iteration using 1,000 randomly selected 
SNPs where approximately 10% of the genotypes were masked and therefore imputed 
by the program fastPHASE. The error rate is taken to be the discordance of the 
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genotypes assayed and imputed by fastPHASE averaged over the ten iterations. The 
parameter K = 14 had the lowest error rate across the values considered. 
To quantify the haplotype diversity in the different populations, we randomly 
selected a region of 500 kb in each chromosome, specifically avoiding regions with 
low SNP density and centromeres, and only considered SNPs common to the seven 
population panels from HapMap and SGVP. The haplotype clustering and 
visualization were then performed using haplosim and hapvisual from the R package 
haplosuite67. Briefly, for each region across n individuals, a similarity matrix for the 
2n chromosomes is first constructed. An eigen-decomposition is then performed on 
this correlation matrix, which allows the inference of the number of distinct haplotype 
forms, or canonical haplotypes for this region. Each canonical haplotype is defined as 
a specific haplotype configuration which is found highly similar in a substantial 
proportion across the 2n chromosomes. Each chromosome is then either mapped 
uniquely to a specific canonical haplotype or a mosaic of these haplotypes. The 
number of canonical haplotypes was set to seven as there were seven distinct 
populations considered. The output from the haplotype clustering procedure was then 
input into hapvisual which produced a visualization of the haplotype clustering for 
each population and maintaining the same color scheme for the canonical haplotypes.   
 
Analysis of LD 
Pairwise LD between two SNPs are calculated from the phased haplotypes 
using the program Haploview23, quantified by the three metrics of (i) square of 
genetic correlation, r2 (ii) Lewontin D’ (iii) LOD score. We only considered SNPs 
with minor allele frequency of 5% or greater and located within a physical genomic 
distance 250 kb apart.  
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We also compared the extent of regional LD variation between all pairs of 
populations across HapMap and SGVP with the varLD program42; 68, where we 
consider windows of 50 consecutive common SNPs in both populations. Candidate 
regions with the strongest regional LD differences between two populations were 
identified as the top 5% of the varLD score distribution for the particular population 
pair.  
 
Detecting signatures of recent positive selection 
Two methods for detecting positive selection were used: (i) Integrated 
Haplotype Score (iHS)6 for identifying regions of positive selection within each of the 
populations in SGVP and HapMap; and (ii) Cross-Population Extended Haplotype 
Homozygosity (XP-EHH)7 for comparison of signals of positive selection between a 
population pair. We first define the extended haplotype homozygosity (EHH) as the 
probability of identity-by-descent for two randomly chosen haplotypes carrying the 
core SNP/haplotype of interest within 1Mb around the core region. This metric would 
be used in both iHS and XP-EHH, and is calculated for each SNP.  
In the integrated haplotype score (iHS) method, ancestral allele information 
for the SNPs was obtained from the Haplotter website (http://haplotter.uchicago.edu/ ) 
, with the non-ancestral allele denoted as the derived allele for the SNP. For each 
SNP, we compute the EHH value for each neighboring SNP, extending in both 
directions (5’ and 3’) until one of the following conditions are encountered: (i) a SNP 
has a EHH score of 0.05; (ii) gap between adjacent SNPs is more than 200kb; (iii) the 
distance from the first SNP to the last SNP on the genomic window considered is 
more than 2.5Mb. If gaps between adjacent SNPs are from 20kb to 200kb, a scaling 
factor was then applied to correct for the artificial inflation due to the large gap. The 
iHS value for a SNP will also not be calculated if any one of the following conditions 
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occur: (i) minor allele frequency of that SNP is less than 5% (ii) derived allele cannot 
be determined or is not any of the two possible alleles of that SNP in SGVP (iii) EHH 
metric did not drop below 0.05 within 2.5Mb. The raw iHS values were calculated by 
first integrating the EHH curve for both the ancestral and derived alleles and then 
taking the logarithm of the ratio of the integrals. The iHS values obtained were then 
standardized to a mean of zero and standard deviation of one in frequency bins each 
spanning 5% according to the derived alleles. Non-overlapping 100kb regions with 
unusual density of SNPs with high iHS scores (at least 10 SNPs with |iHS| > 2) are 
considered candidate regions of recent positive selection.  
The XP-EHH test evaluates the evidence of selection across two populations 
at a selected core SNP for a stated direction in each chromosome by considering all 
common SNPs within 1Mb from the core SNP. In this study, the HapMap YRI 
population was chosen to be the reference population for which every other 
population is compared to. This test is only valid if there is at least one SNP in the 
region considered with an EHH value between 0.03 and 0.05, calculated with respect 
to all chromosomes in both populations. If more than one such SNP can be found, 
then the SNP with the EHH value closest to 0.04 will be considered. In each 
populations, the integral of the EHH at all SNPs between the core SNP and this latter 
SNP is calculated. The XP-EHH log-ratio is then obtained by taking the logarithm of 
the ratios of the integrals calculated earlier from both populations, and the collection 
of all XP-EHH log ratios for all pairs of populations is then standardized to a 
distribution with zero mean and unit variance. The positive tail of the standardized 
score distribution thus suggest the occurrence of a selection event in one population 
but not the other, while the negative tail of the distribution suggest the selection event 
in the latter but not former population. The XP-EHH results merely act to serve as 
confirmation of the candidate selection signals obtained by iHS, and thus a liberal 
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threshold is applied where absolute XP-EHH scores above 2.5 are considered 




We first explored the extent of population structure that exist (i) between all 
populations in SGVP and Hapmap; (ii) within the SGVP populations;  and (iii) in the 
far East Asian populations of Han Chinese (CHB, CHS) and Japanese (JPT) (Figure 
8). On a global genetic diversity, the SGVP populations are genetically more similar 
to the Hapmap European (CEU) and Hapmap East-Asian (JPT + CHB) samples than 
to the African samples in Hapmap YRI. The first axis of variation distinguished the 
African YRI samples from the non-African population groups, while the second axis 
of variation differentiated the Europeans (CEU) from the Asian population groups. 
The Japanese (JPT) and Han Chinese groups (CHB, CHS) virtually overlap, making it 
almost indistinguishable. The Malays (MAS) and Indians (INS) in SGVP displayed 
varying degrees of genetic differences between CEU and the Far East-Asian cluster 
(JPT, CHB, CHS), with INS samples closer to the CEU cluster and MAS closer to the 
Far-East Asian cluster (Figure 8a). The third axis of variation distinguished INS from 
CEU, while MAS is differentiated from the Far East-Asian cluster in the fourth axis 
of variation (Figure 8b). Comparing only populations within SGVP, we find that INS 
is differentiated from CHS and MAS in the first axis of variation, while the second 
axis of variation differentiated CHS from MAS (Figure 8c). These results also 
concurred with the 𝐹𝑆𝑇 measures where comparing the SGVP populations against 
YRI, CHS was the most differentiated at 𝐹𝑆𝑇 = 9.8%, INS being the least 
differentiated at 𝐹𝑆𝑇 = 6.6%, and MAS falling in between with 𝐹𝑆𝑇 = 8.7%. 
Comparing just the populations in SGVP, the INS samples were genetically more 
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diverse, obtaining 𝐹𝑆𝑇 = 3.9% with CHS and 𝐹𝑆𝑇 = 2.7% with MAS, while CHS and 
MAS seemed closer genetically with 𝐹𝑆𝑇 = 0.6%. Analyzing just the populations in 
the Far East-Asian cluster, we were also able to differentiate between the various 
populations. In the first axis of variation, JPT is distinguished from the two Han 
Chinese groups, and CHS seems to be slightly more differentiated from the Japanese 
than the CHB samples (Figure 8d; Table 3: 𝐹𝑆𝑇 for JPT =0.3% with CHB; 0.4% with 
CHS).  The two Chinese groups are then distinguished from each other in the second 
axis of variation (Figure 8d; Table 3: 𝐹𝑆𝑇 = 0.2%). Although in the analysis, there 
were clearly a few CHB samples found in the CHS cluster and vice versa, majority of 
the samples are still clustered well within their respective population labels and 
having a clear separation between the two Chinese groups. We believe this genetic 
separation in the Chinese groups is due to a north-south cline separation of Northern 
and Southern Chinese represented by CHB and CHS respectively.  
 
 
Figure 8: Principal component analysis (PCA) plots showing the genetic diversity of 
populations in Hapmap and SGVP.  
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Each point corresponds to an individual whose spectrum of genetic diversity is represented by the two 
axes of variation corresponding to the two eigenvectors in PCA. Individuals from the same population 
are color-coded according to the legend of color scheme as shown on the left, and is used consistently 
throughout the different panels. a) broad genetic diversity of the populations in Hapmap and SGVP in 
the first two axes of variation b) broad genetic diversity of the populations in Hapmap and SGVP in the 
third and fourth axes of variation c) Comparison of genetic diversity within SGVP populations in the 
first two axes of variation d) Comparison of genetic diversity in the 3 Far East-Asian population groups 
in Hapmap and SGVP (CHB, JPT, CHS) in the first two axes of variation.    
 
Table 3: Pairwise FST calculation based on 1,423,464 SNPs that are common to all of the seven 
HapMap and SGVP populations. Table is from REF61.   
Pop A Pop B HAPMAP 
FST 
SNP-specific FST 





CEU CHB 0.0502 0.0534 (0.0533, 0.0535) 0.0070 0.0289 0.0738 
CEU JPT 0.0505 0.0545 (0.0544, 0.0546) 0.0072 0.0300 0.0757 
CEU CHS 0.0629 0.0532 (0.0532, 0.0534) 0.0069 0.0283 0.0740 
CEU INS 0.0164 0.0199 (0.0198, 0.0199) 0.0024 0.0095 0.0268 
CEU MAS 0.0508 0.0450 (0.0449, 0.0451) 0.0056 0.0235 0.0624 
CEU YRI 0.0770 0.0711 (0.0710, 0.0712) 0.0119 0.0432 0.1010 
CHB CHS 0.0015 0.0050 (0.0049, 0.0050) 0.0006 0.0025 0.0064 
CHB JPT 0.0034 0.0090 (0.0090, 0.0090) 0.0010 0.0048 0.0118 
CHB INS 0.0206 0.0351 (0.0350, 0.0352) 0.0045 0.0178 0.0483 
CHB MAS 0.0031 0.0108 (0.0107, 0.0108) 0.0013 0.0054 0.0142 
CHB YRI 0.0852 0.0817 (0.0815, 0.0818) 0.0143 0.0495 0.1158 
JPT CHS 0.0043 0.0086 (0.0086, 0.0086) 0.0010 0.0041 0.0114 
JPT INS 0.0203 0.0361 (0.0360, 0.0361) 0.0048 0.0184 0.0500 
JPT MAS 0.0053 0.0137 (0.0136, 0.0137) 0.0018 0.0063 0.0179 
JPT YRI 0.0851 0.0827 (0.0826, 0.0829) 0.0144 0.0495 0.1178 
MAS YRI 0.0871 0.0747 (0.0745, 0.0748) 0.0128 0.0443 0.1070 
INS YRI 0.0663 0.0633 (0.0632, 0.0635) 0.0097 0.0378 0.0901 
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LD differences and Haplotype Variation 
The decay of LD with increasing physical distance in each of the SGVP 
populations were generally similar to that observed in the HapMap populations, with 
INS and CHS having the least and greatest amount of conservation of LD in the 
SGVP populations respectively, while the YRI showed the least conservation of LD 
for all seven populations considered which was consistent with previous findings69 
(Figure 9). This is also similar to the number of tagging SNPs needed to capture the 
common SNPs in the various populations at r2 threshold of 0.8, with the least number 
needed in CHS, and most required for INS in the SGVP populations (Table 4).   
 
 
Figure 9: Decay of linkage disequilibrium(LD) with physical distance.  
Figure is from REF61. The decay of LD as quantified by the measure r2 with increasing distance of up 
to 250Kb for each of the seven populations in SGVP and HapMap. The LD calculation was performed 
on 90 randomly selected chromosomes from each population, and only common SNPs with minor 
allele frequencies of at least 5% were used in the analysis. 
 
 Table 4: Number of tag SNPs required to capture all 979,573 common SNPs in each of the SGVP 
and HapMap populations with varying threshold of r2. Table is from REF61. 
 SGVP HapMap 
r2 threshold CHS MAS INS CEU CHB JPT YRI 
r2 ≥ 0.5 195,462 205,927 228,701 211,011 209,167 205,956 367,593 
r2 ≥ 0.8 349,814 371,631 406,814 370,941 364,540 358,898 546,250 
r2 = 1.0 633,161 670,423 680,740 562,479 547,233 530,642 679,687 
 39 
Using varLD to identify genomic regions of differential LD structure between 
populations, we identified 301 common regions in the comparisons between all 
possible pairs of populations from SGVP study and 264 of these overlapped with 
regions that were also identified in at least one comparison pair of the HapMap 
populations. These regions included the dopamine D2 receptor (DRD2) gene 
implicated in schizophrenia70, and growth and appetite regulation71; the epidermal 
growth factor receptor (EGFR) associated with increased susceptibility to lung 
cancer72; 73; and two genes (GCKR, XKR6) that were reported to be associated with 
blood lipoprotein concentration74. Between the two Chinese groups of CHS and CHB, 
654 regions of differential LD structure were identified and were also identified in at 
least one pair of HapMap populations. Three of these regions were in the vicinity of 
candidate genes for common metabolic disorders (FABP2, PCSK1, CLOCK) that 
have been implicated for climate adaptations75. The alternate allele frequencies at the 
A54T (rs1799883) polymorphism in FABP2 was significantly lower in CHS (22.4%) 
and MAS (15.7%) as compared to CHB (31.4%) and JPT (30.0%), which was 
consistent with reported findings of correlation with latitude75. 
The CDKAL1 gene was reported to be associated with Type 2 diabetes across 
diverse population groups, including Europeans76-79, Chinese80; 81, Koreans82 and 
Japanese83. We find that the region encompassing the implicated variant rs7754840 in 
the CDKAL1 gene was highly differentiated in LD patterns between multiple 
population pairs analyzed, even between the two far East-Asian panels of CHS and 
CHB+JPT (Figure 10). The extensive variation in LD in this region is also reflected 
by the haplotype diversity where different populations consist of different sets of 
dominant haplotypes (Figure 11). 




Figure 10: Variation of LD and population-specific recombination rates in the CDKAL1 gene.  
Figure is from REF61. The panel at the first row shows the standardized varLD scores between pairs of 
populations in SGVP and HapMap at the CDKAL1 gene, with the dotted lines denoting the actual gene 
position. The panels at the second and third row shows the pairwise LD heatmap with the population-
specific recombination rates (except for CHB and JPT which used the combined HapMap estimated 




Figure 11: Haplotype diversity at the CDKAL1 gene.  
Haplosim identified 7 canonical haplotypes for this region on chromosome 6 spanning 20.654 – 
21.341Mb, and a unique color is assigned to each canonical haplotype. Each chromosome is mapped 
either totally to one unique canonical haplotype or as a mosaic of the 7 canonical haplotypes. The 
scatterplot denotes the frequencies of two canonical haplotypes in each of the seven populations.  
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Signatures of positive natural selection 
Most of the signals of positive natural selection identified in the SGVP 
populations concur with those found earlier in the HapMap populations, which 
included those with well documented functions such as the alcohol dehydrogenase 
(ADH) gene cluster in CHS and INS; skin pigmentation genes (SLC24A5 in INS) and 
low-density lipoprotein cholesterol (LDLR in CHS and INS, APOB in CHS, MAS and 
INS).  
The FTO gene has been shown to be implicated for the onset of Type 2 
diabetes and obesity. An independent study on obesity performed on the three ethnic 
groups in Singapore genotyped the implicated SNP rs9939609 that was reported to 
have an association to obesity in the European populations. The association was 
replicated in the Chinese and Malays but not in the Singapore Indians, even though 
the frequency of the associated allele is more similar between Indians (freq in INS = 
41.6%) and Europeans (freq in CEU = 45.0%) than in the Chinese (freq in CHS = 
12.5%) or Malays (freq in MAS = 5.3%). Signatures of selection were also observed 
in the FTO gene in all three populations (Figure 12a). Two SNPs (rs7194907 and 
rs8053888) had the strongest selection signals in CHS (|iHSnorm| = 2.82) and MAS 
(|iHSnorm| = 3.06), but not in INS (|iHSnorm| = 0.60 and 0.57 respectively). Conversely 
the SNP with the strongest selection signal (rs1107356, |iHSnorm| = 2.97) in INS was 
not selected in either CHS (|iHSnorm| = 0.05) or MAS (|iHSnorm| = 0.49). A consistent 
trend was observed in CHB+JPT, with marginal signals observed in the former two 
SNPs (|iHSnorm| = 1.91) but not in rs1107356 (|iHSnorm| = 0.07). Comparing the 
haplotypes of the populations in SGVP and HapMap in the FTO gene, we observed 
that a different dominant haplotype exists in INS as compared to the other populations 
of CHB+JPT, CHS or MAS (Figure 12b).  This suggests that separate selection 
events on the underlying functional allele have occurred on two different haplotype 
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backgrounds, which potentially confounds replication studies aiming to reproduce 
association signals established against one haplotype background. 
 
Figure 12 Signals of positive selection at FTO.  
a) defines the region on chromosome 16 (51.0 – 54.0 Mb) encapsulating the FTO gene and highlights 
where significant variations in patterns of LD are observed in specific pairs of comparisons. Signatures 
of positive selection are also overlaid, with purple corresponding to CHS, yellow for MAS and cyan for 
INS. The dotted lines indicate the start and end of the FTO gene. b) Visualization of the haplotypes at 
the FTO gene is provided where each of the chromosomes has been assigned either to a canonical 
haplotype or as a mosaic of 6 possible canonical haplotypes. Each canonical haplotype is assigned a 
unique color scheme. We have grouped the seven populations (CHS, CHB, JPT, MAS) into four 
clusters according to the similarities in haplotype memberships. Note that the box width for each 
population is dependent on the number of chromosomes analyzed for that population.  
 
DISCUSSION 
The Singapore Genome Variation Project is established with the aim to 
provide a genetic resource for the three major ethnic groups of Chinese, Malay and 
Indians in Singapore that can be used to aid in the design and analysis of genetic 
association studies of complex human diseases and traits on these population groups. 
This is achieved where genetic data on 1.6 million polymorphisms assayed on 268 
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unrelated individuals from the three ethnic groups are made publicly available in a 
similar structure to the International HapMap Project (Figure 13).  
 
 
Figure 13  Screen capture of the SGVP genome browser.  
A screen capture of the publicly available genome browser at http://www.statgen.nus.edu.sg/cgi-
bin/gbrowse/sgvp/ for assess, view and download of data from the SGVP genetic resource. 
 
With the dense genetic data from the SGVP resource, we are able to map the 
SGVP populations on a global genetic diversity together with the four HapMap 
population groups. Comparison of the three Far East-Asian populations of Singapore 
Chinese, Han Chinese from Beijing and Japanese revealed fine but yet detectable 
levels of genetic differences. Between the two Chinese groups, a fine-scale population 
substructure was found suggesting a reflection of the genetic diversity found between 
Northern and Southern parts of China. This is further supported by evidence at the 
FABP2 gene where the genetic variant that confers greater tolerance to cold climates 
is found in lower frequency in the Singapore Chinese as compared to the Han Chinese 
from Beijing in North China. This variant is also found at low frequency in the 
Singapore Malays.  
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Exploring the extent of variation in regional patterns of linkage disequilibrium 
and haplotype structure between populations revealed a number of genomic regions 
which are phenotypically interesting and have variable success in replicating the 
genetic association to the phenotype of interest. We have also identified signatures of 
positive selection in the SGVP resource, with most observed signals corresponding to 
the similar reported regions of selection in the HapMap populations. A number of 
novel candidate regions of positive selection in the SGVP populations were also 
identified which required further investigation.  
The next phase of medical genomics studies will attempt to localize the 
functional causal variants in the genomic regions identified earlier from the GWAS 
studies. Imputation is a popular strategy for localizing the disease causal variant, 
where genotypes of SNPs in the implicated region are statistically inferred based on 
information available in a set of reference haplotypes. The accuracy of this statistical 
procedure is very much dependent on the suitability of the haplotypes in the reference 
panel to the target study population. Availability of ethnic-specific reference 
haplotypes from the SGVP resource provides the prospect of accurately determining 
the genotypes of SNPs in the region, and thus increasing the coverage in the region. 
 
SUMMARY 
The Singapore Genome Variation Project complements other public genetic 
resources such as HapMap and Human Genome Diversity Project (HGDP) by 
providing a easily available and accessible public genetic resource of 1.6 million 
polymorphisms in 268 unrelated individuals from three major population groups in 
Asia (South Han Chinese, Malays and Indians residing in Singapore).  We believe this 
set of dense genome-wide data will be able to: (1) serve as or add to the reference 
panels for imputation to increase the coverage of GWAS studies performed on similar 
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populations in Asia; (2) rank and prioritize the associated SNPs identified from 
GWAS studies on similar populations in Asia for further validation; and (3) to 
perform genome-wide LD comparisons between populations to identify regions where 
trans-ethnic fine-mapping could be utilized to narrow the associated candidate region 
from GWAS studies to localize the functional causal variant, which is the subject of 



















Chapter 4 – Trans-ethnic genome-wide association studies meta-
analysis for association discovery and fine-mapping of causal 
variants 
MOTIVATION 
The catalog of published genome-wide association studies (GWAS)84 
currently consist of 1,315 publications with 6,630 SNPs reported to be associated with 
various complex human diseases and traits (correct as on 19th July 2012). In order to 
identify causal genetic variants that are common across populations and variants with 
smaller effects, it is now common to meta-analyze multiple GWAS studies of diverse 
populations to increase the number of individuals studied. The initial GWAS and 
genome-wide meta-analysis studies (GWMA) were conducted primarily on 
populations with European ancestries. Increasingly such studies are now being 
performed on populations with African ancestries85; 86, East and South Asian 
populations87-89 and on admixed populations such as the African-Americans90; 91. 
Many of the initial findings were replicated in these non-European populations and 
additional novel loci were identified which are likely to be either population specific 
or the frequency of the implicated risk allele are more common in these non-European 
populations. The KCNQ1 gene is an example of a risk loci that was first identified to 
be associated to Type 2 diabetes in East-Asians and later replicated in the European 
populations as the associated risk alleles are at higher frequencies in East-Asians 
compared to Europeans92; 93.  
   Currently, the culmination of the associated SNPs identified in multiple 
GWAS studies have only managed to explain a small proportion of the phenotypic 
variance observed94, though it is widely believed the heritability estimates would be 
increased significantly when the true causal variants are identified as the associated 
SNPs are merely proxies of the causal variants. This is illustrated in the instance 
where variance estimates were effectively doubled when the causal variant for low-
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density lipoprotein cholesterol was identified through fine-mapping95. However, fine-
mapping of causal variants by targeted re-sequencing presents significant challenges, 
as the extensive linkage disequilibrium (LD) in the region of the associated locus 
which has been useful in association discovery could confound the identification of 
the causal variant by having a number of highly-correlated SNPs that show 
indistinguishable evidence of association with the unknown causal variant to the 
phenotype of study96; 97 (Figure 14).  
It has been hypothesized that we can localize and identify the common causal 
variant by leveraging the differential LD patterns and haplotypes in multiple diverse 
populations at the associated locus97. We thus sought to investigate if any informative 
metrics exist for identifying regions or populations where (i) association discovery via 
a meta-analysis; and (ii) fine-mapping for causal variant identification are likely to 
succeed.  
We evaluated the following four metrics of population diversity for their 
correlation to the efficiency for trans-ethnic meta-analysis discovery of the associated 
loci; and trans-ethnic fine-mapping for identifying the causal variants on simulated 
data: (i) regional FST which evaluate the diversity between populations by differences 
in SNPs’ allele frequencies; (ii) degrees in similarity of haplotypes between 
populations using haplotype entropy and similarity; and (iii) varLD to assess the 
extent of differences in levels of LD between populations. We also applied these four 
metrics on 43 established genetic loci associated with Type 2 diabetes in the European 
populations to assess their efficiency for trans-ethnic meta-analysis association 
discovery and identification of the causal variant by fine-mapping with addition of 




Figure 14 Identification of causal variant within regions of differential LD patterns.  
Figure is from REF97 a) LD heatmap of a region containing a causal variant with low levels of LD 
present between pairs of SNPs b) statistical evidence of association for the SNPs in this region to the 
trait of interest in a GWAS study c) statistical evidence of association for additional SNPs identified by 
fine-mapping the implicated loci with targeted re-sequencing and earlier evidence of association from 
the GWAS SNPs. Panels d-f show similar information as panels a-c but for a causal variant in a region 
with high levels of LD. The extent of strong LD in the region depicted in d will result in a number of 
SNPs showing similar levels of statistical association, making it difficult to differentiate the true causal 
variant from the strongly linked SNPs. The situation is worsened by the identification of more strongly 
linked SNPs identified from targeted re-sequencing of the region.    
 
METHODS 
Simulated case-control datasets 
We used the publicly available phased haplotype data from the autosomal 
chromosomes of 1,387,394 SNPs from 988 unrelated individuals in the 11 population 
groups from HapMap Phase 334 and population-averaged recombination rates from 
HapMap Phase 233 as seed for simulation of case-control genetic datasets. For 
simulation of causal variants, we first removed all non-polymorphic SNPs across the 
11 population groups and SNPs present on the Illumina Human1M genotyping array. 
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The remaining SNPs which are therefore the polymorphic SNPs in HapMap Phase 3 
assayed only on the Affymetrix SNP6.0 genotyping array constitute the set of 
candidate causal variants. These SNPs are then grouped into three disjoint frequency 
bins according to their minor allele frequency (MAF) in the CEU population: (i) high 
MAF defined as 0.2 ≤ MAF ≤ 0.5; (ii) medium MAF defined as  0.05 ≤ MAF < 0.2; 
and (iii) low MAF defined as  0.01 ≤ MAF < 0.05.  
To determine how regions with high levels of LD will affect fine-mapping of 
causal variants, for each MAF frequency bin we randomly identified 1,000 SNPs 
which are also perfectly correlated in LD structure (r2 = 1) with at least five 
neighboring SNPs within 100kb region in the CEU population as the simulated causal 
variants. In each of the 11 population groups, 4,000 pairs of cases and controls 
samples were simulated using the HAPGEN program98, assuming a multiplicative 
disease effect and allelic relative risk of 1.2 at each of the causal variant. This implies 
a common causal variant is present in each of the 11 population groups and strong 
levels of LD exist within the neighboring SNPs to the common causal variant in the 
CEU population, but levels of LD are variable in the other 10 population groups. The 
effective population size parameter were assumed to be 11,418 for European and 
South-Asian populations (MEX, TSI, CEU, GIH); for East-Asian populations (JPT, 
CHD, CHB) to be 14,269; and 17,469 for African populations (YRI, MKK, LWK, 
ASW).  
      
Association and meta-analyses 
The program SNPTEST45 (version 1.1.5) was used in the case-control 
association analysis with the frequentist additive test of association which is 
equivalent to a logistic regression. The standard fixed effects meta-analytic approach 
is used in the meta-analysis of diverse populations by pooling the logarithm of the 
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odds ratios in each population and weighting by the inverse of the square of the 
standard errors. 
Two analytical approaches are taken: (i) the “Association” approach where we 
consider a GWAS study was performed using the Illumina Human1M genotyping 
array which will therefore exclude all of the simulated causal variants; and (ii) the 
“Fine-map” approach where all SNPs in the HapMap Phase 3 dataset including the 
simulated causal variant in the genomic region considered are evaluated for evidence 
of statistical association. In the “Association” approach, we wish to measure the 
strongest statistical evidence of association in each simulated region and the changes 
in statistical association when populations are analyzed together in a meta-analysis. In 
the “Fine-map” approach, we wish to measure the relative ranking of the strength of 
statistical association evaluated at the simulated causal variant when different 
combinations of populations are considered. 
 
Population diversity metrics 
Genome-wide population diversity between the HapMap Phase 3 populations 
were assessed using principal component analysis and FST. The pca program 
distributed in the software EIGENSTRAT65 was used to determine the first 20 
principal components across a thinned set of 60,466 common SNPs in the 11 HapMap 
Phase 3 populations. We also calculated a genome-wide FST from the mean of the 
distribution of all autosomal SNP-specific FST values which is the proportion of 
variance in allele frequencies of the SNP between the populations. 
For assessment of the local genetic diversity within each causal variant, we 
applied the following four localized population diversity metrics on all SNPs within 
50kb of the causal variant on either flanks.  
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Regional FST 
The regional FST metric is similar in calculation to the genome-wide FST but 
restricted only to SNPs within 50kb of either flanks from the causal variant and is 
calculated by the mean of the distribution of each SNP-specific FST values for the 
SNPs bounded within the region. Greater genetic diversity between populations in the 
region, reflected by wider variations in the allele frequencies of the SNPs are 
represented by larger values of the regional FST metric which is bounded between 0 
and 1.   
Haplotype Entropy 
We first identify the set of L unique haplotypes that occur in at least 2% in 
each of the K populations, defined as (h1, h2, … hL). Then, for each population j, we 
tabulate the frequency of each haplotype hi to obtain a population-specific haplotype 
frequency fij with fi as the frequency of haplotype hi across all K populations. The 
posterior probability for population j conditional on haplotype hi is therefore 𝐹𝑖𝑗 = 𝑓𝑖𝑗 ∑ 𝑓𝑖𝑗𝐾𝑗⁄ . The relative mutual information for haplotype hi can therefore be defined 
as 𝑅𝑀𝐼(ℎ𝑖) =  1 +  ∑ (𝐹𝑖𝑗 log𝐹𝑖𝑗)𝐾𝑗 log (𝐾)⁄ . The haplotype entropy metric is 
therefore a measure of population specificity of haplotypes and can be defined as the 
sum of the individual relative mutual information estimates weighted by frequency, or 
∑ [(∑ 𝑓𝑖𝐿𝑖 )𝑅𝑀𝐼(ℎ𝑖)]𝐿𝑖 (∑ 𝑓𝑖𝐿𝑖 )⁄  and is bounded between 0 and 1. Higher values of this 
metric reflect higher degrees of haplotype diversity across populations indicate that 
specific haplotypes are more common in some populations only. 
Haplotype Similarity 
Within the 100kb region of the causal variant, we first identify the set of all 
unique haplotypes that are present in the K populations considered. The proportion of 
all haplotypes represented by these unique haplotypes across the K populations, which 
is a value bounded between 0 and 1 is therefore defined as the haplotype similarity 
 52 
metric. Larger values indicate a significant proportion of shared haplotypes between 
the populations and therefore lower haplotype diversity across the populations.  
Composite varLD 
We quantified the extent of differences in levels of LD between populations 
with the varLD statistic42; 68 by performing genome-wide varLD calculation for every 
population pair in the HapMap Phase 3, considering windows of 50 consecutive SNPs 
and subsequently standardizing the distribution of varLD scores to a mean of zero and 
standard deviation of one. For quantifying the extent of LD of each simulated causal 
variant, the standardized varLD score for the SNPs window centered nearest to the 
genomic location of the causal variant was considered. If three or more populations 
are analyzed together, a composite varLD measure is calculated by taking the mean of 
the standardized varLD scores for all population pairs. Low levels of inter-population 
LD differences are indicated by larger negative values of the composite varLD metric, 
while large differences in LD levels between populations result in high positive 
values of the composite varLD metric.  
 
Application to T2D implicated loci 
In studies performed on European populations, 43 established loci displaying 
consistent evidence of association to Type 2 diabetes were determined45; 78; 99-104 
(Table 5) and the index or proxy SNP for each loci in the respective studies were 
identified. We then applied the four localized population diversity metrics described 
earlier on the SNPs within 50kb on either flanks of the index or proxy SNP for each 





chromosome position rsID Nearest gene 
1 120328505 rs1493694 NOTCH2 
1 212230298 rs340835 PROX1 
2 27594741 rs780094 GCKR 
2 43586327 rs7578597 THADA 
2 60438323 rs243021 BCL11A 
2 160874480 rs4077463 RBMS1 
2 226801989 rs2943641 IRS1 
3 12368125 rs1801282 PPARG 
3 23311454 rs7612463 UBE2E2 
3 64686944 rs4607103 ADAMTS9 
3 124548468 rs11708067 ADCY5 
3 187011774 rs1470579 IGF2BP2 
4 6343816 rs10010131 WFS1 
5 76460705 rs4457053 ZBED3 
6 20769229 rs7754840 CDKAL1 
7 15030358 rs10244051 DGKB/TMEM195 
7 28155936 rs1635852 JAZF1 
7 44202193 rs4607517 GCK 
7 130117394 rs972283 KLF14 
8 96006678 rs7845219 TP53INP1 
8 118253964 rs13266634 SLC30A8 
9 8869118 rs17584499 PTPRD 
9 22123284 rs10965250 CDKN2A/B 
9 81141948 rs13292136 CHCHD9 
10 12368016 rs12779790 CDC123/CAMK1D 
10 94455539 rs5015480 HHEX/IDE 
10 114748339 rs7903146 TCF7L2 
11 1653425 rs2334499 HCCA2/DUSP8 
11 2648047 rs231362 KCNQ1 
11 2803645 rs163184 KCNQ1 
11 17365206 rs5215 KCNJ11 
11 72110746 rs1552224 CENTD2 
11 92313476 rs1387153 MTNR1B 
12 64456430 rs2612067 HMGA2 
12 69899543 rs1353362 TSPAN8/LGR5 
12 119887315 rs7305618 HNF1A 
13 79615157 rs1359790 SPRY2 
15 60183681 rs7172432 C2CD4A/B 
15 78219277 rs11634397 ZFAND6 
15 89322341 rs8042680 PRC1 
16 52402988 rs11642841 FTO 
17 2163008 rs391300 SRR 
17 33172153 rs4430796 HNF1B (TCF2) 
Table 5: List of 43 loci that have shown consistent evidence of association to Type 2 diabetes in 
studies on European populations. Table is from REF105 . 
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RESULTS 
Different outcomes are measured for the two analytical approaches in our 
study. In the “Association” approach, the outcome is measured as being able to 
identify an association signal for the region containing the causal variant with 
genome-wide significance of P-value < 5 x 10-8. In the “Fine-map” approach, the 
outcome is measured by the simulated causal variant having the strongest association 
signal i.e. smallest P-value of all the SNPs within the genomic region. 
 
Genome-wide population diversity 
Our simulations suggested that when only one population is considered in the 
genetic association discovery (Figure 15, K = 1), the Europeans seem to have the 
highest power as compared to the other population groups for causal variants with 
MAF > 0.2. This is however an artifact as causal variants were simulated with the 
allele frequencies and patterns of LD in the CEU population panel and similar 
patterns can be observed when causal variants are simulated under similar conditions 
in the YRI population panel (Figure 16). In the meta-analysis for association 
discovery, there is a inverse correlation in power to the genome-wide FST of the 
populations analyzed together such that population configurations with high genome-
wide FST have decreased power of association discovery (Figure 15, K = 2, 3, 4). 
There is however no apparent correlation between the genome-wide FST of the 
various combinations of populations analyzed to the ability of fine-mapping the 
causal variants. Fine-mapping analysis with African populations however seem most 
successful in identifying the causal variant with the strongest statistical association 
regardless of the number of African populations analyzed together, thus indicating 
genome-wide FST is unlikely to be a good measure for the efficiency of trans-ethnic 
fine-mapping. These observations were also consistent for the causal variants 
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simulated for the medium (0.05 ≤ MAF < 0.2) (Figure 17) and low (0.01 ≤ MAF < 
0.05) (Figure 18) MAF frequencies bins105.  
 
Figure 15 Performance of meta-analysis association and fine-mapping with diverse 
populations for variants with strong levels of LD and having 0.20≤MAF<0.50 in 
CEU.   
Figure is from REF105. Causal variants with minor allele frequency between 20% to 50% and having 
perfect correlation in LD structure with at least 5 neighboring SNPs in CEU population were simulated 
across all populations in HapMap Phase 3. Legends for each columns of panels can be found at the last 
row, depicting the population configurations and the respective genome-wide FST values. a) Power for 
association discovery in a single population and for meta-analyses of two to four populations at varying 
sample sizes b) Rank attained by the statistical association at each simulated causal variant (in 
ascending P-value) by fine-mapping with one to four populations. A causal variant is correctly 
identified if it is ranked the first (fine-map rank = 1) as having the strong statistical association or 
lowest P-value among the SNPs in the region. c) Power for identifying the causal variant by fine-






Figure 16 Performance of meta-analysis association and fine-mapping with diverse 
populations variants with strong levels of LD and having 0.20≤MAF<0.50 in YRI  
Figure is from REF105. Causal variants with minor allele frequency between 20% to 50% and having 
perfect correlation in LD structure with at least 5 neighboring SNPs in YRI population were simulated 
across all populations in HapMap Phase 3. Legends for each columns of panels can be found at the last 
row, depicting the population configurations and the respective genome-wide FST values. a) Power for 
association discovery in a single population and for meta-analyses of two to four populations at varying 
sample sizes b) Rank attained by the statistical association at each simulated causal variant (in 
ascending P-value) by fine-mapping with one to four populations. A causal variant is correctly 
identified if it is ranked the first (fine-map rank = 1) as having the strong statistical association or 
lowest P-value among the SNPs in the region. c) Power for identifying the causal variant by fine-






Figure 17 Performance of meta-analysis association and fine-mapping with diverse 
populations for variants with strong levels of LD and having 0.05≤MAF<0.20 in 
CEU.   
Figure is from REF105. Causal variants with minor allele frequency between 5% to 20% and having 
perfect correlation in LD structure with at least 5 neighboring SNPs in CEU population were simulated 
across all populations in HapMap Phase 3. Legends for each columns of panels can be found at the last 
row, depicting the population configurations and the respective genome-wide FST values. a) Power for 
association discovery in a single population and for meta-analyses of two to four populations at varying 
sample sizes b) Rank attained by the statistical association at each simulated causal variant (in 
ascending P-value) by fine-mapping with one to four populations. A causal variant is correctly 
identified if it is ranked the first (fine-map rank = 1) as having the strong statistical association or 
lowest P-value among the SNPs in the region. c) Power for identifying the causal variant by fine-






Figure 18 Performance of meta-analysis association and fine-mapping with diverse 
populations for variants with strong levels of LD and having 0.01≤MAF<0.05 in 
CEU.   
Figure is from REF105. Causal variants with minor allele frequency between 1% to 5% and having 
perfect correlation in LD structure with at least 5 neighboring SNPs in CEU population were simulated 
across all populations in HapMap Phase 3. Legends for each columns of panels can be found at the last 
row, depicting the population configurations and the respective genome-wide FST values. a) Power for 
association discovery in a single population and for meta-analyses of two to four populations at varying 
sample sizes b) Rank attained by the statistical association at each simulated causal variant (in 
ascending P-value) by fine-mapping with one to four populations. A causal variant is correctly 
identified if it is ranked the first (fine-map rank = 1) as having the strong statistical association or 
lowest P-value among the SNPs in the region. c) Power for identifying the causal variant by fine-








Regional population diversity 
 
Figure 19 Pairwise relation of the four metrics of local population diversity.  
Figure is from REF105.  Each panel shows the relation between pairs of the local population diversity 
metrics measured in the meta-analysis for two to four populations. A density style plot is made in each 
panel where greater concentration of data points are indicated by warm colors of yellow to red, while 
sparse densities are represented by the cool colors of violet to blue (zero density). 
 
We then applied the four metrics of local population diversity described earlier 
in the 100kb region of the causal variants (50kb on either flanks) on the simulated 
datasets. Haplotype similarity appeared to be negatively correlated with haplotype 
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entropy while no apparent relation can be identified between the other metrics 
pairings (Figure 19). 
 
Figure 20 Comparison of statistical power with the localized population diversity metrics for 
variants with strong levels of LD and having 0.20≤MAF<0.50 in CEU. 
Figure is from REF105. Causal variants with minor allele frequency between 20% to 50% and having 
perfect correlation in LD structure with at least 5 neighboring SNPs in CEU population were simulated 
across all populations in HapMap Phase 3. Legend for all panels are identical and can be found at the 
bottom right corner of this figure. The first row of panels show the power of identifying association in 
meta-analysis of two to four population groups, while the bottom row of panels show the power of 








Figure 21 Comparison of statistical power with the localized population diversity metrics for 
variants with strong levels of LD and having 0.20≤MAF<0.50 in YRI. 
Figure is from REF105. Causal variants with minor allele frequency between 20% to 50% and having 
perfect correlation in LD structure with at least 5 neighboring SNPs in YRI population were simulated 
across all populations in HapMap Phase 3. Legend for all panels are identical and can be found at the 
bottom right corner of this figure. The first row of panels show the power of identifying association in 
meta-analysis of two to four population groups, while the bottom row of panels show the power of 









Figure 22 Comparison of statistical power with the localized population diversity metrics for 
variants with strong levels of LD and having 0.05≤MAF<0.20 in CEU. 
Figure is from REF105. Causal variants with minor allele frequency between 5% to 20% and having 
perfect correlation in LD structure with at least 5 neighboring SNPs in CEU population were simulated 
across all populations in HapMap Phase 3. Legend for all panels are identical and can be found at the 
bottom right corner of this figure. The first row of panels show the power of identifying association in 
meta-analysis of two to four population groups, while the bottom row of panels show the power of 









Figure 23 Comparison of statistical power with the localized population diversity metrics for 
variants with strong levels of LD and having 0.01≤MAF<0.05 in CEU. 
Figure is from REF105. Causal variants with minor allele frequency between 1% to 5% and having 
perfect correlation in LD structure with at least 5 neighboring SNPs in CEU population were simulated 
across all populations in HapMap Phase 3. Legend for all panels are identical and can be found at the 
bottom right corner of this figure. The first row of panels show the power of identifying association in 
meta-analysis of two to four population groups, while the bottom row of panels show the power of 
identifying the causal variant in trans-ethnic fine-mapping. 
 
Next, we analyzed the summary of each localized population diversity metric 
obtained earlier, by taking the mean of each metric within each configuration across 
all simulated data in meta-analysis of two to four populations (Figures 20-23). In 
meta-analysis association, the average regional FST (Pearson correlation ρ = -0.67, P-
value = 2.7 x 10-4) and haplotype entropy (Pearson correlation ρ = -0.83, P-value = 
3.0 x 10-7) are both negatively correlated with the statistical power of association 
discovery. A positive correlation is observed between haplotype similarity and the 
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statistical power (Pearson correlation ρ = 0.64, P-value = 6.0 x 10-4), while the 
composite varLD score shows no correlation nor association to statistical power of 
association discovery (P-value = 0.151). The statistical power for fine-mapping of 
causal variants is not associated with both regional FST (P-value = 0.361) and 
haplotype entropy (P-value = 0.591), but shows a moderate association with 
haplotype similarity (Pearson correlation ρ = -0.47, P-value = 0.017) and is positively 
correlated with composite varLD measure (Pearson correlation ρ = 0.70, P-value = 
8.7 x 10-5). Although the extent of these findings (Figure 20) varied with the MAFs 
of the causal variants (Figures 22-23), the overall trends of the correlations were 
consistent. These suggest different metrics are necessary between the two analytical 
approaches, where haplotype entropy and regional FST are better indicators for 
efficiency of association identification, while composite varLD and haplotype are 
better at indicating the efficiency of fine-mapping.   
We also studied the relationship between the four metrics of local population 
diversity with the efficiency of trans-ethnic meta-analysis when four populations are 
meta-analyzed together (K = 4) (Figures 24-26). For every decile of each metric, we 
identify 100 out of 1000 causal variants and calculate (i) change in statistical evidence 
of association (denoted by -log10P-values) of the causal variant between meta-
analysis of four population groups and most significant result obtained from single 
population association and (ii) empirical power of identifying the causal variant by 
counting the number of identified causal variants (out of 100) as having achieved the 
strongest statistical evidence of association in the region. We observed that haplotype 
entropy and regional FST are negatively correlated with the change in statistical 
evidence of association discovery in the meta-analysis, where low haplotype entropy 
and FST values can cause ten-fold increases in the –log10P-values (Figure 24A and 
B). No association was observed between change in statistical evidence of association 
discovery and for both haplotype similarity and composite varLD (Figure 24C and 
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D). Interestingly, when deciles of the metrics are considered, we observed a moderate 
association between haplotype entropy and regional FST to power of identifying the 
causal variants by fine-mapping, where higher haplotype entropy and decreasing FST 
values correspond to increases in power (Figures 24E and F). Similar to the earlier 
observation, higher degrees of haplotype similarity correspond to a decrease of 
statistical power of identifying the causal variant (Figure 24G). There does not seem 
to have any correlation between composite varLD and the power of identifying the 
causal variant by fine-mapping. (Figure 24H). 
 
 
Figure 24 Comparison of meta-analysis efficiency with the four metrics of local population 
diversity for variants with strong levels of LD and having 0.20≤MAF<0.50 in 
CEU.  
Figure is from REF105. Meta-analysis are performed on all combinations of 4 population groups (K = 
4). Legend for all panels are identical and can be found at the bottom right corner of this figure. The 
first row of panels show the efficiency in association discovery, while the second row of panels show 




Figure 25 Comparison of meta-analysis efficiency with the four metrics of local population 
diversity for variants with strong levels of LD and having 0.05≤MAF<0.20 in 
CEU.  
Figure is from REF105. Meta-analysis are performed on all combinations of 4 population groups (K = 
4). Legend for all panels are identical and can be found at the bottom right corner of this figure. The 
first row of panels show the efficiency in association discovery, while the second row of panels show 





Figure 26 Comparison of meta-analysis efficiency with the four metrics of local population 
diversity for variants with strong levels of LD and having 0.01≤MAF<0.05 in 
CEU.  
Figure is from REF105. Meta-analysis are performed on all combinations of 4 population groups (K = 
4). Legend for all panels are identical and can be found at the bottom right corner of this figure. The 
first row of panels show the efficiency in association discovery, while the second row of panels show 
the efficiency in fine-mapping of the causal variant. 
 
Application to Type 2 Diabetes implicated loci 
For each of the 43 identified loci (Table 5), we applied the four metrics of 
local population diversity on the genetic data within 100kb region of the respective 
loci across the four populations of CEU, CHB, JPT and YRI (Figure 27). We 
observed that loci with high haplotype entropy and regional FST values such as 
TCF7L2, PRC1 and JAZF1 (Figure 27A) are found to be associated to Type 2 
Diabetes in South-Asians106, but are not replicated in the East-Asians and South-East 
Asian Malays89, while loci with low haplotype entropy and regional FST such as IRS1, 
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SLC30A8 and CDKAL1 are consistently replicated in both East and South Asians87; 89. 
Loci such as CDKAL1, PRC1, IRS1 and THADA should probably have a higher 
chance at identifying causal variants in fine-mapping of the loci as these loci have 
either low degrees of haplotype similarity or high levels of variation in LD between 
populations (Figure 27B).     
 
DISCUSSION 
Our results suggest that both haplotype entropy and regional FST are indicative 
of the efficiency of meta-analysis association discovery in multiple diverse 
populations where lower values of either metric correspond to increased statistical 
power of association discovery. Differential levels of LD and haplotype similarity 
between populations are however better indicators for assessing the efficiency in fine-
mapping of causal variants diverse populations where high varLD scores and low 
degree of haplotype similarity correspond with increased statistical power for 
identification of causal variants. 
We believe that metrics such as haplotype entropy and regional FST which are 
essentially an comparison of the SNP alleles’ frequencies across the different 
populations are informative of the meta-analysis efficiency in association discovery, 
as a genomic region with low haplotype entropy and regional FST likely indicate: (i) 
the frequency of the risk allele are similar across the populations; (ii) the risk allele 
was already present in the ancestors’ genetic profile for these populations; and/or (iii) 
a common haplotype is shared across the populations which carries the risk allele. 
Similarly, metrics such as haplotype similarity and varLD which assess the diversity 
of haplotypes across the populations in the region are informative of the efficiency of 
trans-ethnic fine-mapping as the risk allele might be present in different haplotypes in 
 69 
the different populations which can mitigate the effect of the long range LD present in 
any one population.  
 
 
Figure 27 Localized population diversity at 43 Type 2 diabetes loci.  
Figure is from REF105. Each loci is annotated by its nearest gene name, and represented in different 
colors for pure aesthetic reasons for easy differentiation. (A) Genes with their corresponding values of 
haplotype entropy and regional FST where lower values of either metric correlate with increased power 
for finding associations in meta-analyses; (B) Genes with their corresponding values of composite 
varLD and haplotype similarity where higher varLD and lower haplotype similarity values correspond 
with increased power of identifying the causal variant. THADA has a varLD score of 3.2. 
For a genetic risk allele that is susceptible to disease outcome, we note that the 
risk allele can: (i) reside on a shared haplotype or (ii) reside on different haplotypes 
across the populations. In the first instance, there is one dominant haplotype which is 
very common in most populations and this can be quantified by the haplotype entropy 
metric, while in the second instance, there are different haplotypes in the populations 
but all of which carry the risk allele which is quantified by the haplotype similarity 
metric. Similarly, the two instances correspond to different situations about the extent 
of levels of LD between the SNPs in the region, where in the first instance high levels 
of LD or r2 exist between SNPs across the populations while differential LD or r2 




Currently there are various efforts to meta-analyze multiple GWAS studies on 
diverse populations for association discoveries and prioritizing of candidate regions 
for fine-mapping of causal variants. Towards this effort, we have identified four 
metrics, each of which is appropriate for the different applications. Non-replication of 
association signals in other populations is inevitable and the two metrics: haplotype 
entropy and regional FST can be applied to quantify if genetic diversity in the region 
of association between the populations studied is likely a strong contributing factor. 
Similarly for trans-ethnic fine-mapping of identifying the causal variants, we have 
shown that metrics like varLD and haplotype similarity will be useful in prioritizing 













Chapter 5 – A method for identifying haplotypes carrying the 
causative allele in genome-wide association studies and positive 
natural selection 
MOTIVATION 
In a genome-wide association study (GWAS), a locus is considered to be 
reliably associated to the phenotype of study if a list of neighboring SNPs in the 
region show similar levels of statistical association, with several of these SNPs 
reaching genome-wide statistical significance. By the nature of LD, most if not all of 
the associated risk alleles at these SNPs are likely to reside on a common haplotype 
which is also carrying the functional risk allele at the unknown causal variant. 
Leveraging on the genetic diversity of multiple distinct populations, we can fine-map 
and localize the boundaries for the causal variant to regions that are common and 
consistent across the different population-specific implicated risk haplotypes. 
The lengths of haplotypes in human populations are usually short as 
recombination acts over time to break down the extents of LD in genomic regions. 
This is however not the case for regions experiencing strong positive selection5. For 
an advantageous allele that has an positive impact on fitness which is defined as the 
ability to both survive and reproduce, strong positive selection will rapidly increase 
the frequency of the haplotype carrying the advantageous allele to high frequency or 
even fixation in the population. By the effects of genetic hitch-hiking, the linked 
neutral loci will remain in strong levels of LD with the selected allele as 
recombination will not have sufficient time to occur thus resulting in haplotypes that 
are uncharacteristically long for a given haplotype frequency. Several computational 
methods such as iHS6 and XP-EHH7 relied on the identification of long haplotypes in 
genomic regions for finding candidate regions of positive selection. These methods 
generally however do not identify the length and form of the selected haplotype.   
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We therefore introduce a method for finding haplotypes in three situations: (1) 
haplotypes that carry a specific combination of alleles from a list of user-defined 
SNPs; (2) identifying the longest haplotype for a user-defined core haplotype 
frequency carrying a specific allele at a focal SNP; and (3) identifying the longest 
haplotype at a specified focal position at a defined core haplotype frequency. In the 
first situation (Type 1 application), the method can be used to identify the haplotype 
that carries most if not all of the implicated risk alleles at the associated SNPs 
identified from GWAS studies. In the second (Type 2 application) and third (Type 3 
application) situations, the method can be used to identify the positively selected 
haplotype, where in Type 2 we know a priori the identify of the selected SNP and the 
advantageous allele while in Type 3 only the approximate position of the selected 
SNP is known (which is commonly the situation where there is evidence of positive 
selection from iHS or XP-EHH but not on the exact location of the SNP and the 
corresponding allele that is selected).    
 
METHODS 
The three applications in HapFinder require as input, the phased haplotype 
data for the population considered in a N x L matrix where N = 2n is the number of 
phased haplotypes for n individuals on L bi-allelic SNPs. Each entry in the N x L 
matrix consist of either 0 or 1, representing the two alleles for each SNP. Note that we 
assume there would not exist any missing allele information as current statistical 
phasing procedures would infer the most likely allele for missing data. The other 
necessary input files are: (1) a legend file which contains the snp identifier, genomic 
coordinates and denoting the mapping of the 0/1 encodings to the actual DNA bases 
of the alleles for each SNP and (2) a sample file containing the ordered list of unique 
sample identifiers for each individual by their pair of chromosomes sorted in the 
 73 
phased haplotype data. The format of the three input files are identical to the phased 
haplotype data from HapMap Project31-33. A schematic overview for HapFinder 
briefly describing the workflow of the three applications is shown in Figure 28.  
 
 
Figure 28  Schematic overview of the three applications in HapFinder. Figure is from REF 107.  
 
Algorithm for Type 1 
Type 1 application of HapFinder attempts to identify the haplotype forms 
carrying most if not all of the target alleles at the corresponding specified focal SNPs. 
Weights are assigned for the identical match of the target allele at each of the K focal 
SNP by either the SNP weightings or the genetic distances between the SNPs or as a 
composite function of both methods. In the context of identifying the associated 
haplotype in a GWAS study which carries the target risk alleles at associated focal 
SNPs, the SNP weightings (q1, q2,…, qk) could therefore be the evidence of statistical 
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association at each SNP such as –log10 P-values or log Bayes factors. Independently, 
the genetic distances of the SNPs (d1, d2,…, dk) could also be used as weights where 
we define a focal position dcenter as the mean of the genetic distances of the first and 
last focal SNP specified. The weight at each SNP can thus be defined as follows 
 
 
which will result in a similarity match score bounded between zero and one to be 
calculated for each chromosome in the phased haplotype dataset. Users can also 
specify a similarity score threshold, where HapFinder will only identify and report 
haplotypes whose match score is above the specified threshold. If a threshold of one is 
specified, only the haplotype forms which carry all the target alleles at every focal 
SNP are identified, while a specified threshold less than one implies discordance of 
target alleles at some focal SNPs will be tolerated so long as the overall similarity 
match score of the chromosome is above the threshold. 
 
Algorithm for Type 2 
In this HapFinder application, the aim is to identify the longest haplotype 
carrying a particular target allele at a specific focal SNP occurring at the user-
specified core haplotype frequency f in the phased haplotype dataset. From the core 
haplotype frequency f specified, we first determined the critical number of 
chromosomes, c = floor[f x N] which is the stop condition for this algorithm when the 
number of chromosomes in the dataset containing the longest haplotype falls below 
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this value. Initially if the number of chromosomes with the target allele is less than c, 
the algorithm terminates immediately, else we prefix the SNP at the immediate left of 
the focal SNP to create a two-loci haplotype which could consist of either one or two 
combinations of the haplotype forms depending on if the prefixed SNP is 
monomorphic or polymorphic in the haplotype database. When the number of 
chromosomes carrying the more common two-loci haplotype is at least c, we prefix 
the next adjacent SNP on the left to the current haplotype considered to form a three-
loci haplotype. The algorithm thus iterates between prefixing the next adjacent SNP 
on the left to create a longer haplotype and checking if the number of chromosomes 
carrying the most common haplotype is at least c. When the number of chromosomes 
carrying the most common haplotype is less than c, the last prefixed SNP on the left is 
removed from the haplotype and the adjacent SNPs to the right of the focal SNP will 
be appended to create longer haplotypes until the number of chromosomes carrying 
the most common longest haplotype is less than c. The last appended right SNP to the 
haplotype will be removed, and the longest haplotype spanned is then output as the 
result.         
 
Algorithm for Type 3 
The algorithm for Type 3 is almost identical to that of Type 2 except that a 
focal position is specified instead of a focal SNP and there is no specification of a 
target allele. In this instance, the SNP which is nearest to the focal position specified 
will thus be selected as the focal SNP and the two alleles present at the focal SNP will 
be considered as target alleles. The algorithm thus proceeds by effectively running 
two instances of HapFinder for the Type 2 application for the same focal SNP but 
with different target alleles. The output from the two runs of HapFinder Type 2 
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application will then be consolidated and the longest haplotype from the two analyses 
will be output as the result.  
Fuzzy Matching in Type 2 and Type 3 
Genotyping errors are inevitable in most GWAS studies where hundreds of 
thousands to a million SNP markers are assayed and called simultaneously by 
automated genotype calling algorithms on thousands of individuals. To accommodate 
for the presence of genotyping errors which will likely propagate to the haplotypes 
obtained through statistical phasing, we allow a small proportion of mis-matches 
when counting the number of chromosomes in the haplotype database carrying the 
most common haplotype. A similarity score is calculated between the most common 
haplotype and each of the chromosomes in the phased haplotype dataset by the 
proportion of SNPs whose alleles are identical across the length of the haplotype. 
When the similarity score is greater than the user-specified similarity threshold s*, the 
chromosome is thus considered to be sufficiently similar to the most common 
haplotype. Therefore, instead of requiring the chromosome to be identical to the most 
common haplotype, fuzzy matching with s* < 1 counts the number of chromosomes 
that are highly similar to the most common haplotype.   
 
Software implementation and output format 
A Java program for HapFinder is freely available for download from 
http://www.statgen.nus.edu.sg/~SGVP/software/hapfinder.html, together with R 
scripts for plotting the results. Each of the three application in HapFinder generates 
four common output files: (i) a .haps file consisting of the identified haplotypes with a 
string of 0 or 1s, where each row correspond to a chromosome and each column a 
SNP with the values of 0/1 encoding specific alleles; (ii) a .legend file with the 
mapping information of the SNPs ordered in the haps file with the corresponding SNP 
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identifier (rsid), genomic coordinates and alleles encoding for 0/1 with the respective 
DNA bases; (iii) a .sample file that indicates the identifier of the chromosome for an 
individual present in the haps file (sample identifiers are appended by a 1/2 for the 
first and second chromosome for that individual); and (iv) a .log file of the execution 
of HapFinder program which contains all of the candidate haplotypes considered for 
each application type. We note that the first three output files correspond to the 
identical format of the input files necessary for HapFinder (HapMap phased haplotype 
file format) except for the sample file where we need to specify the specific 
chromosome which carries the identified haplotype. For Type 1 application, a fifth 
file will be output: (v) a .snp file which consist of the snp identifier, genomic 
coordinates, allele that is tagging the identified haplotype and the LD measured in r2 
between each SNP and the identified haplotype.  
 
Dataset 
The three application types of HapFinder were applied on the publicly 
available phased haplotype data on three population panels: CEU, YRI and JPT+CHB 




HapFinder Type 1 
 
Figure 29 Example of Type 1 application in HapFinder for identifying the haplotype form 
carrying the implicated risk alleles at associated SNPs. 
Figure is from REF107. The three rows of panels show the haplotype identified by HapFinder to carry 
most of the risk alleles at associated SNPs (right panel) found to be significantly associated (P-value < 
10-6) in the association analysis (left panel) for each of the three HapMap Phase 2 population panels for 
a simulated causal variant with risk allele of T at a SNP (rs2206734, indicated by a vertical dashed line 
in the regional association plot) located within the CDKAL1 gene. SNP locations on the haplotype are 
indicated by a vertical bar and the alleles are all color coded to represent the four possible DNA bases 
(A – green, C – blue, G – yellow, T – red). SNPs with non-unique alleles found in the identified 
haplotype would be represented in grey. Although different SNPs are found associated in each 
population, the three identified haplotypes for each population all carry the simulated risk allele T at 
the simulated causal SNP (represented by a red line joining the T allele to the SNP on the haplotype). 
 
For each of the three population panels in HapMap, 2000 pairs of case control 
samples were simulated using the program HAPGEN98 with an artificially simulated 
causal variant at a SNP (rs2206734) found within the CDKAL1 gene on chromosome 
6 which was shown to display significant LD variations between populations61, 
assuming a multiplicative disease effect with allelic relative risk of 1.5 at the T allele. 
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The association analysis for each population was restricted to SNPs present only on 
the Illumina 1M genotyping array and with the simulated causal SNP masked (Figure 
29). SNPs showing significant evidence of statistical associated (P-values < 10-6) are 
identified as input SNPs for HapFinder, together with the associated risk alleles and 
the corresponding P-values as SNP weightings. In each population panel, we ran Type 
1 application of HapFinder to identify the haplotype forms carrying most if not all of 
the risk alleles at the associated input SNPs with a similarity score threshold of 0.98. 
We observed that although the association analysis identified different SNPs to be 
significantly associated in the three population panels, the haplotype forms that are 
identified by HapFinder all carried the simulated risk allele T at the simulated causal 
SNP across the three populations (Figure 29). We also repeated the simulation on 
1000 randomly selected SNPs present in all three population panels and observed that 
84.4% of the haplotype forms identified by HapFinder all carried the risk allele at the 
SNP variant that was simulated to associate with higher disease risk across all three 












HapFinder Type 2 
 
 
Figure 30  Example of Type 2 application in HapFinder for identifying the positive selected 
haplotype carrying the selected A allele in the sickle cell locus of rs334. 
Figure is from REF107. HapFinder Type 2 application were run with parameters of core haplotype 
frequency, f = 0.10 and similarity score, s* = 0.98 for all focal SNPs. (A) Identification of the longest 
haplotype found by HapFinder Type 2 at focal SNP rs334 for target alleles of the selected A allele and 
wildtype T allele. The alleles on each haplotype are color coded for each of the four possible DNA 
bases (A – green, C – blue, G – yellow, T – red), while the black vertical lines on the horizontal grey 
bar represents the location of each SNP in the region, with the red vertical line and triangle indicating 
the location of SNP rs334. (B) Comparison of the differences in lengths of the longest haplotypes 
identified for both alleles on 1000 randomly selected SNPs with MAF of 12.5% in YRI where the red 
triangle represents rs334. The three random SNPs showing the largest extent of differences are shaded 
in orange, while the grey dashed diagonal lines represent the boundaries for the various sizes of the 
ratio of the haplotype lengths.  
 
Sickle cell anemia is an inherited blood disorder caused by mutations in the 
beta globin HBB gene, most commonly at SNP rs334 on the p15.5 arm of 
chromosome 11. The wildtype allele at rs334 is the thymine allele (allele T on the 
positive strand) which encodes for the normal Hb A form of hemoglobin, while the 
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adenine allele (allele A on the positive strand) encodes for the hb S form of 
hemoglobin where only individuals that are homozygous for the adenine allele 
(genotype AA) will have sickle cell anemia. The sickle cell adenine allele although 
having a recessive Mendelian risk of sickle cell anemia, is shown to be under 
balancing selection in the HapMap Yoruba population (YRI)108; 109 by conferring up 
to a 10-fold protection against malaria which is a deadly infectious disease in Africa85; 
110; 111. Thus due to the effects of positive selection, the sickle cell adenine allele is 
expected to reside on an uncharacteristically long haplotype as compared to other 
alleles in the genomes of the YRI population not under selection pressures at similar 
frequencies. We thus proceed to validate this by running HapFinder Type 2 
application on the phased haplotypes from HapMap Phase 2 YRI population on 
chromosome 11, where the genotype data on SNP rs334 in the population are 
available. We performed two separate analyses with the adenine and thymine alleles 
as the target alleles on the same focal SNP rs334 and having a common core 
haplotype frequency of 10%. The longest haplotype form carrying the sickle cell 
adenine allele spans a physical distance of nearly 0.4Mb while the longest haplotype 
form carrying the wildtype thymine allele at rs334 has a length less than 40Kb 
(Figure 30A). Running HapFinder Type 2 application on another 1000 randomly 
chosen SNPs each having a MAF of 12.5% in YRI, we find that only 3 random SNPs 
have similar extent of differences in lengths of the longest haplotypes found for the 






HapFinder Type 3 
 
 
Figure 31  Example of Type 3 application in HapFinder for identification of the selected 
haplotype by varying the focal positions around the selected variant (rs334) 
Figure is from REF107. The figure shows the longest haplotype identified by Type 3 application in 
HapFinder for 3 distinct focal positions around the sickle cell locus (including the causal rs334 variant 
at focal position 5204808) at core haplotype frequency of 5%. The alleles on each haplotype are color 
coded for each of the four possible DNA bases (A – green, C – blue, G – yellow, T – red). The longest 
haplotype identified at focal position 5204808 corresponds to finding the longest haplotype at focal 
SNP rs334 carrying the selected A allele. The bottom panel shows that the three identified longest 
haplotypes are highly similar irrespective of the focal positions specified, while the top panel presents a 
segment window of 40kb around rs334 which shows all three identified haplotypes carry the selected A 
allele. 
 
The sickle cell locus provides a positive example where we know a priori the 
selected causal variant and allele, but in most situations we can only identify 
candidate regions showing evidence of positive selection with methods such as iHS 
and XP-EHH. In such cases where only the broad genomic regions are known without 
any specific knowledge of the selected focal SNP or allele, we can use Type 3 of 
HapFinder to identify the likely haplotype which carries the unknown functional 
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allele. Using the sickle cell locus as an example, we show that similar haplotype 
forms are identified regardless of the focal positions specified when the analysis are 
performed for the different focal positions at and near to the selected variant (Figure 
31). This demonstrates the utility in identifying the selected haplotype form for a 
candidate region identified by either iHS or XP-EHH to be positively selected. 
Similarly, by varying the core haplotype frequencies considered at a focal 
position, we could localize and narrow the likely frequency that the selected allele 
occurs in the population. When the core haplotype frequency considered are within 
the limits of the frequency of the selected allele, the longest haplotypes identified are 
likely to carry the selected allele and when the core haplotype frequency is greater 
than the selected allele frequency, the longest haplotype identified might likely carry 
the non-selected allele instead thus resulting in a significant decrease in the lengths of 
haplotypes identified (Figure 32). We thus performed three separate Type 3 
HapFinder analysis in the HBB gene region in YRI population, with focal positions 
specified at 5,204,808 bp (rs334) and two neighboring positions of 5,200,000 bp and 
5,210,000 bp and also varying the core haplotype frequencies in each analysis from 
20% to 5% in step-size reduction of 1%. Significant increases in haplotype lengths 
were observed at the core haplotype frequencies of 12%, 11% and 9% for the 
different focal positions considered (Figure 32A top panel). Measuring the 
proportion of discordant sites for the common overlapped regions between the longest 
haplotypes identified at two consecutive frequencies, we observed that the high 
discordance coincided at the core haplotype frequency where there was also a 
substantial increase in the differences in lengths of the longest haplotype identified. A 
large value for discordance typically indicates that different haplotypes have been 
identified between the two consecutive frequencies and likely reflects the cross over 
of the haplotypes carrying the different alleles at the causal variant. We also repeated 
the analysis on another gene region (LARGE gene in YRI) that has been previously 
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reported to be positively selected for protection against lassa fever in North Central 
Africa7 at the putative selected variant of SNP rs481698 and having frequency of 
33.3% in YRI for the selected allele. Similarly, we observed that as the core haplotype 
frequency considered decreases from 34% to 33%, there is a significant increase in 
the lengths of the longest haplotype identified and also corresponding to a high degree 
of discordance between the haplotypes.  
 
 
Figure 32  Two Examples of Type 3 application in HapFinder that can be used to localize and 
narrow the likely frequency of the selected allele in the population.  
Figure is from REF107. For each of the two genomic regions, we specified the genomic position of the 
known selected variant and two other neighboring genomic positions as input focal positions and 
recorded the length of the longest haplotype identified across a range of core haplotype frequencies in 
Type 3 application of HapFinder as shown in the top panel. The bottom panel of each region shows the 
change in the lengths of the longest haplotype identified (red lines and circles) and the degrees of 
discordance (grey lines and circles) for varying core haplotype frequencies for the known selected 
variant. (A) Type 3 application in HapFinder analysis performed in the HBB gene in YRI with 
selection at rs334 with frequency 12.5% in YRI. (B) Type 3 application in Hapfinder analysis 
performed in the LARGE gene in YRI with selection at rs4481698 with frequency of 33.3% in YRI.     
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DISCUSSION 
We have introduced a method for finding haplotypes in three situations that 
are relevant to the analysis of GWAS studies and positive natural selection. Applying 
Type 1 application of HapFinder on simulated case control data, the method is able to 
identify the haplotypes carrying the risk alleles at associated SNPs for each 
population panel which also carries the risk allele of the simulated causal variant 
across the populations. Using the sickle cell locus, we are also able to illustrate the 
utility of the method in finding the selected haplotype form (Type 2) and estimating 
the likely frequency of the selected allele (Type 3).  
In medical genetics, the field is now moving away from the association 
discovery of loci for complex diseases and traits in GWAS studies to the fine-
mapping of the causal variant in the associated loci to understand the biological 
mechanisms of disease progression. LD which was useful in the initial association 
discovery phase of GWAS becomes a liability in fine-mapping studies as it becomes 
difficult to differentiate between the causal variant and the neighboring SNPs that are 
in strong or perfect LD with the causal variant showing indistinguishable evidence of 
statistical association. Our method can first be used to identify the haplotype forms 
carrying most of the risk alleles in the different populations and subsequently leverage 
on the differences in population-specific haplotypes in a trans-ethnic population 
analysis setting to identify the common genomic regions across the populations to 
localize the causal variant105.   
Extending the work of Type 3 application of HapFinder to every SNP across 
the genome, we can identify haplotypes that are uncharacteristically long for a core 
haplotype frequency which could be due to positive selection pressures acting on the 
region. This may thus provide an alternative method for identification of putative 
positively selected regions, though there is a need to account for local effects of LD 
which could bias the analysis.  
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SUMMARY 
We have developed a method, HapFinder that can be used in a medical 
genetics setting to identify the haplotype forms carrying most if not all of the risk 
alleles identified from GWAS studies for different populations which subsequently 
can be used to localize the causal variant to regions where these population-specific 
haplotypes are consistent across populations. The method can also be used to identify 
haplotypes carrying selected alleles in positively selected regions and may provide an 


















Chapter 6 – Conclusion 
Initially, large-scale SNP data was only available on the HapMap populations 
but with declining costs of genotyping, we now have dense SNP data available on 
multiple diverse populations. These densely available SNP data will allow a fine-scale 
resolution of LD patterns in the human populations such that we are now able to 
understand the average history of the populations as well as also understand the 
history of specific genomic regions which could be the effects of ancient admixture in 
humans112-114.  
This thesis has focused on the LD patterns between bi-allelic SNPs which is 
currently the most common form of genetic variation studied in humans due to its 
widespread interest as markers in GWAS studies. Much lesser attention has been 
given to the study of LD patterns between other kinds of genetic variations such as 
small indels (insertions and deletions), microsatellites and structural variants36; 47; 115 
which could potentially have selective effect. Similarly due to technological and 
power limitations, we have not been able to identify SNPs with lower minor allele 
frequencies which have been thought to be recent mutations in the populations. 
Fueled by rapidly decreasing costs and advancements in high-throughput next-
generation sequencing technologies, it is now possible to sequence one complete 
human genome at a fraction of the time and cost of the initial Human Genome 
Project. This has allowed the 1000 Genomes Project (1KGP) to undertake the whole 
genome sequencing of around 2,500 individuals from more than 20 population groups 
to catalog human genetic variations occurring at a population frequency of 1% or 
more. The pilot phase of the project116 on the four population groups of CEU; YRI 
and CHB+JPT identified close to 15 million SNPs and 1.5 million indels with 55% of 
the SNPs and 57% of the indels novel as compared to the entries in dbSNP. Initial 
studies117 showed that the levels of LD among the low frequency and with the 
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common frequency SNPs are much lower as compared to among the common 
frequency SNPs. This led manufacturers to introduce much denser genotyping arrays 
for GWAS studies, assaying between 2.5 million to 5 million SNPs in the human 
genome as researchers delve into variants at the lower end of the allelic frequency 
spectrum to investigate if the missing heritability not identified in the GWAS studies 
on common variants may be explained by these rare variants. 
 For researchers who have already genotyped a large number of individuals on 
the earlier generation of genotyping platforms, genotype imputation to infer the lower 
frequency SNPs using the very much dense and complete variant data from 1KGP 
provides a very attractive cost-savings alternative. The drawback to this approach 
would be the differential levels of LD between the study population and the reference 
panel which could affect the accuracy of imputation. Various studies118 have thus 
suggested the use of a cosmopolitan reference panel such as the 1KGP which consist 
of multiple diverse populations when a population-specific reference panel is not 
available. 
We have thus embarked on two whole-genome sequencing studies on the local 
populations of Singapore Malays and Singapore Indians with the aim of provide a 
sequence-level genetic variation data resource similar to 1KGP on the two local 
population groups. We hope to study the levels of LD in these two populations among 
themselves and with the populations in 1KGP especially on the low and rare 
frequency variants, with the dual aims of studying population history and leveraging 
the population differential levels of LD in medical genetics for identification of the 
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